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The L-Type calcium channel (LTCC) is a heteromultimeric protein complex with an 
important function in cardiac biology since it ensures the main entry path for calcium 
into the cardiomyocytes. Its conductance increases during membrane depolarization, 
whereas decreases during calcium- and voltage-dependent inactivation. In addition, G 
protein-coupled receptor (GPCR) signaling provides a further regulatory layer for fine-
tuning the LTCC (Catterall, 2000; van der Heyden et al., 2005).  
The α1C subunit is the main pore forming subunit of the LTCC, which is expressed at 
high levels in cardiomyocytes and is encoded by the CACNA1C gene (Weiss et al., 
2013). It comprises of a cytosolic N- and C-terminal tails and four transmembrane 
domains, which harbor the ion-selective pore, voltage sensor and gating machinery 
(Carafoli et al., 2001). Its C-terminal tail (CT) serves as a scaffold for channel 
modulating molecules downstream of the GPCR signaling, including kinases and 
phosphatases (Catterall, 2000). Over the past few decades the LTCC regulation via β-
AR/Gs protein systems was well demonstrated. However, little attention has been paid 
to its regulation via alternative GPCR-like systems such as Wnt11/Calcium pathway 
(Panáková et al., 2010). 
The present study provides evidence that Wnt11 signaling regulates the LTCC, hence 
the electrical gradient formation in developing zebrafish heart. I showed that loss of 
WNT11 induces the generation of a CT isoform in A-kinase anchoring protein (AKAP) 
anchored Protein kinase A (PKA) signaling dependent manner. Systematic analysis of 
all the AKAP candidates revealed that PKA targeting through AKAP2 to the CT plays 
a pivotal role in this isoform formation. In developing zebrafish heart Akap2 is 
indispensable for the proper heart looping and regulates the LTCC localization and 
abundance. In cooperation with the Wnt11 pathway it establishes the electrical 
gradient formation, since loss of akap2 rescued the abnormal cell coupling in wnt11-
deficient hearts. These findings provide evidence that Wnt11 signaling 
compartmentalizes LTCC conductance by targeting PKA/AKAP2 required for the 





Der L-Typ-Calciumkanal (LTCC) ist ein heteromultimerer Proteinkomplex mit einer 
wichtigen Funktion in der kardiovaskulären Biologie, da dieser die hauptsächliche 
Eintrittsmöglichkeit von Calcium in Herzmuskelzellen sicherstellt. Die Leitfähigkeit des 
LTCC steigt während der Membrandepolarisation und sinkt während der Calcium- oder 
Spannungsabhängigen Inaktivierung. Darüber hinaus stellt der G Protein-gekoppelte 
Rezeptor (GPCR) Signalweg eine weitere regulatorische Ebene zur Feinjustierung des 
LTCC dar (Catterall, 2000; M. a G. van der Heyden, Wijnhoven, & Opthof, 2005).  
Die α1C Untereinheit ist hauptursächlich für die Porenbildung des LTCC, wird in 
großen Mengen in Herzmuskelzellen exprimiert und vom CACNA1C Gen kodiert 
(Weiss et al., 2013). Die α1C Untereinheit umfasst einen zytosolischen N- und C-
terminalen Schwanz und vier Transmembrandomänen, welche die ionenselektive 
Pore, den Spannungssensor und die Gating-Maschinerie beherbergen (Carafoli et al., 
2001). Sein C-terminaler Schwanz (CT) dient als Gerüst für kanalmodulierende 
Moleküle stromabwärts des GPCR-Signalwegs, einschließlich Kinasen und 
Phosphatasen (Catterall, 2000). In den letzten Jahren wurde die Regulation des LTCC 
durch das β-AR/Gs Proteinsystem ausführlich bewiesen. Jedoch ist der Regulation 
durch das alternative GPCR-ähnliche System, wie dem Wnt11/Calcium Signalweg, 
dabei wenig Aufmerksamkeit zugekommen (Panáková et al., 2010).  
Die vorliegende Studie erbringt Nachweise, dass der Wnt11-Signalweg den LTCC 
reguliert, und damit einhergehend die elektrische Gradientenbildung im sich 
entwickelnden Zebrafisch Herz. Ich habe gezeigt, dass der Verlust von WNT11 zur 
Erzeugung einer CT Isoform führt, abhänging von der A-Kinase Ankerprotein (AKAP)-
verankerte Protein Kinase A (PKA)-Signalgebung. Eine systematische Analyse aller 
AKAP-Kandidaten ergab, dass PKA über AKAP2 auf den CT abzielt und so eine 
entscheidende Rolle bei der Bildung dieser Isoform spielt. Im sich entwickelnden 
Zebrafischherzen ist Akap2 unentbehrlich für das Looping des Herzens und reguliert 
die Lokalisation sowie Häufigkeit des LTCC. Zusammen mit dem Wnt11-Signalweg 
wird die elektrische Gradientenbildung etabliert, da der Verlust von akap2 die 
abweichende Zellkopplung in wnt11-defizienten Herzen wiederherstellt. Diese 
Erkenntnisse erbringen den Beweis dafür, dass der Wnt11-Signalweg die Leitfähigkeit 
des LTCC kompartmentalisiert, indem er auf die AKAP2/PKA-Interaktion abzielt, 
welche für die korrekte Bildung der interzellulären Kopplung benötigt wird.






1.1 The L-type calcium channel function and structure 
The voltage-dependent calcium channels are a highly conserved family of ion channels 
and play a central role in regulating the electrical and biochemical properties of 
neurons, endocrine and muscle cells, since they ensure predominant route for calcium 
entry into the cells. Based on high voltage activation, slow voltage inactivation, and 
inhibition by calcium antagonist drugs we can distinguish between the major  channel 
types, which are L-, N-, P-, Q-, R- and T-types (Reuter, 1983; Reuter et al., 1982). The 
L-type calcium channels (LTCCs) are the most typical in a wild range of cell types 
beside the T-type, while the other types are more common in neurons. The LTCCs are 
sensitive to dihydropyridines and depending on their abundance in the different cell 
types they are divided into four classes. The Cav1.1 is common in skeletal muscle, the 
Cav1.2 in cardiac muscle, endocrine cells and neurons, the Cav1.3 in endocrine cells 
and neurons, and the Cav1.4 in the retina.  
Activation of the Cav1.2 channels, which are the most abundant in cardiomyocytes 
upon membrane depolarization induces a range of intracellular events. Calcium influx 
establishes action potential duration and triggers calcium induced calcium release from 
the sarcoplasmic reticulum (SR) via ryanodine receptor 2 (RyR2) (Fabiato, 1985). The 
amplified calcium signal subsequently promotes excitation-contraction, excitation-
secretion and excitation-transcription coupling (Carafoli et al., 2001; Clapham, 1995; 
Dirksen & Beam, 1999). In parallel, feedback loops ensure the channel inhibition that 
can result in calcium- or voltage-dependent inactivation. Eventually, the cycle is 
terminated by the calcium reuptake by SR via SR Ca2+-ATPase (SERCA) and 
Phospholamban (PLN), and calcium extrusion via Na+/Ca2+ exchanger (NCX) (Figure 
1). In addition, G Protein-Coupled Receptor (GPCR) signaling provides a further 











The LTCC is a heteromultimeric protein complex that in cardiomyocytes consists of a 
transmembrane α1C subunit, an intracellular β subunit, and α2δ subunit, which is 
associated with the α1C subunit via disulfide bridges. In other cell types it includes an 
additional transmembrane γ subunit (Ellis et al., 1988; Takahashi et al., 1987). The 
α1C subunit (~250 kDa) is the main pore forming subunit, comprises of a cytosolic N- 
and C-terminal tails and four transmembrane domains (I-IV), which contain 6 
membrane spanning α-helices with a membrane associated loop between helix 5 and 
6 (Takahashi et al., 1987). This subunit harbors the ion selective pore, the voltage 
sensor and the gating machinery, and binding sites for the channel modulating 
molecules. The C-terminal tail (CT) consists of the calmodulin (CaM) binding pre-IQ 
and IQ motif, the calcium binding EF-hand, and binding sites for kinases and 
Figure 1: Schematic representation of Ca2+ fluxes in cardiomyocytes. Upon 
depolarization, the calcium influx trough the LTCC triggers the calcium release from the SR, 
and induces excitation-contraction (E-C) and excitation-transcription (E-T) coupling (full 
arrows). The baseline concentration of intracellular calcium after inactivation of the LTCC 
is restored via calcium re-uptake by SERCA and PLN, and extrusion by NCX (dashed 
arrows). LTCC- L-type calcium channel, NCX- Na+/Ca2+ exchanger, RyR2- Ryanodine 
receptor 2, SERCA- Sarcoplasmic Reticulum Ca2+-ATPase, PLN- Phospholamban. 
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phosphatases via the A-kinase Anchoring Protein binding domain (ABD) (Takahashi 






1.2 LTCC regulation  
In cardiomyocytes the intracellular calcium level changes on a time scale of 
milliseconds, which requires a dynamic regulation of the LTCC. This is partially 
achieved via post-translational modifications of the LTCC. It has been shown that in 
some cases the post-translational modification can induce the cleavage of the CT 
generating different CT isoforms. These cleaved CT isoforms can translocate into the 
nucleus, where they can act as transcription factors (TF) and regulate the LTCC 
expression (Gomez-Ospina et al., 2006; Schroder et al., 2009), with this providing a 
dynamic regulatory feedback loop. This is supported with data showing that the protein 




Figure 2: The LTCC complex. Schematic representation of the α1C subunit. It consists of 
4 homologous transmembrane domains, each composed of six membrane spanning α -
helices and intracellular N- and C-terminal tail. The C-terminal tail consists binding site for 
A-Kinase-Anchoring Proteins (ABD - AKAP-Binding-Domain), Calcium (EF hand) and 





1.2.1 Regulation through transcription 
The role of the different CT isoforms in the regulation of the CACNA1C gene 
expression, which encodes the α1C subunit, has been implicated across different cell 
types. Overexpression of the full-length CT (75 kDa) isoform together with full length 
CACNA1C promoter-reporter construct resulted in reduction in the promoter activity. 
Similarly, overexpression of the 40 kDa distal-CT (dCT) isoform had a greater affinity 
to represses the channel expression (Schroder et al., 2009). Further analysis of the 
serum response of the promoter activity revealed that the CT isoforms interact with 
serum-stimulated transcription factors to regulate LTCC expression. This observation 
based on the finding that overexpression of either the CT or dCT construct together 
with CACNA1C promoter deletion construct led to the repression of the promoter 
activity more efficiently in the presence than in the absence of the serum (Schroder et 
al., 2009). 
Further studies revealed that the CACNA1C gene has a cryptic promoter in exon 46 
(in murine gene). The translation of this transcript is independent from the full-length 
gene resulting in a 15 kDa dCT isoform. This fragment is also able to translocate into 
the nucleus where it acts as a TF. Its generation is regulated developmentally. It has 
been shown that the α1C subunit and this fragment are expressed in complementary 
pattern in developing brain, which is consistent with the findings that dCT suppresses 
the CACNA1C expression (Gomez-Ospina et al., 2013). 
Through their transcriptional activity these different CT isoforms can also regulate the 
formation of adhesion complexes and junctional contacts. Their generation and nuclear 
accumulation is regulated developmentally as well as by intracellular calcium (Gomez-
Ospina et al., 2006).  
 
1.2.2 Regulation through post-translational modifications 
In cardiomyocytes, most of the α1C subunits exist as a shorter isoform as opposed to 
predicted 250 kDa full-length due to proteolytic cleavage of the CT generating a 
truncated isoform (210 kDa) and dCT (40 kDa) (De Jongh et al., 1996). In rat α1C 
subunit (A0A0G2QC25) the cleavage occurs between residues aa1631-1645 (Hulme 
et al., 2005), and is initiated by calpain-like proteases (Hell et al., 1996). This proteolytic 
processing results in a non-covalently associated dCT domain, which autoinhibits the 
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LTCC activity (Gao et al., 2001; Hulme, Yarov-Yarovoy et al., 2006), however the 
autoinhibition can be relieved upon phosphorylation of the CT (Fuller et al., 2010).  
 
1.2.2.1 Regulation via Protein Kinase A induced phosphorylation 
The most thoroughly studied pathway in the LTCC regulation is the β-Adrenergic 
Receptor (β-AR)/Gs protein coupled signaling (Gao et al., 1997; Jurevicius & 
Fischmeister, 1996; Sculptoreanu et al., 1993). Upon β-AR stimulation with 
epinephrine or norepinephrine, guanine nucleotide exchange results in the dissociation 
of the Gαs subunit from the Gβγ. The separated Gαs activates the adenylyl cyclase 
(AC), which leads to elevated cAMP levels. The inactive Protein kinase A (PKA) 
holoenzyme comprises two catalytic and dimeric regulatory (RI or RII) subunits. During 
PKA activation cAMP binds to the regulatory subunit, which releases the catalytic 
subunits (Pierce et al., 2002). The activated PKA catalytic subunit is then able to 
phosphorylate its substrates like the CT of the α1C subunit. The phosphorylation by 
PKA abolishes the autoinhibition of the dCT, since it leads to the dissociation of the 
non-covalently associated dCT from the proximal-CT (pCT) (Hulme, Yarov-Yarovoy, 
et al., 2006). As a consequence, the inactivated channels become active, in addition 
the opening probability of the channels increases (Yue et al., 1990). In accordance 
with this it has been shown that loss of the dCT greatly increases the channel activity 
(Wei et al., 1994; Hulme, Yarov-Yarovoy, et al., 2006). Deletion of the dCT fragment 
abolishes the regulation via β-AR system and leads to severe cardiac hypertrophy and 
perinatal death in mice (Fu et al., 2011).  
Whereas both β1-AR and β2-AR positively couple with the stimulatory Gs, only β2-AR 
can induce the inhibitory Gi protein coupled signaling (Abramson et al., 1988). 
Enhanced PKA activity due to β2-AR/Gs stimulation results in the phosphorylation of 
the β2-AR. This phosphorylation induces that the receptor switches its coupling 
specificity to Gi, hence induces the MAP kinase activation (Daaka et al., 1997). One of 
the most studied Gi protein-coupled receptor is the Muscarinic receptor. It has been 
shown that Gi suppresses channel conductance of cardiac cells by activation of 
phosphatases or by changing cGMP-dependent phosphodiesterase (PDE) activity 





stimulation inhibits the Gs coupled receptor signaling through reduction of the cAMP 
levels. 
In the last decades, many studies investigated the relevance of the PKA 
phosphorylation sites on the CT in the LTCC regulation by the β-AR/Gs system, 
however, it is still not clear to date, which phosphorylation sites are essential for the 
proper channel regulation. One of the extensively studied PKA phosphorylation site is 
the serine 1928 (S1928) in murine model, which was initially proposed to play a role in 
the LTCC regulation via β-AR/Gs system (De Jongh et al., 1996; Ganesan et al., 2006; 
Hulme, Westenbroek et al., 2006). This was, however, ruled out using knock in mouse 
with targeted mutation of S1928 to alanine (S1928A), since the mutation had no impact 
on the channel conductance (Lemke et al., 2008). Recently, it has been shown that 
high fat diet induced channel activity was abolished in mice expressing the S1928A, 
suggesting an essential role for α1C phosphorylation at S1928 in stimulating channel 
conductance in the regulation of metabolism (Nystoriak et al., 2017). In addition, serine 
1700 (S1700) was also proposed as an essential phosphorylation site responsible for 
PKA modulation of the channel (Fu et al., 2014; Fuller et al., 2010; Linghai Yang et al., 
2016), but other study reported that PKA phosphorylation of S1700 is not required in 
the adrenergic regulation of the channel (Lin Yang et al., 2013). Furthermore, another 
study suggested the relevance of S1574 by PKA phosphorylation in the channel 
regulation (Minobe et al., 2014), while other paper implicated that none of the 
aforementioned PKA phosphorylation sites are required for the channel regulation in 
cardiomyocytes (Katchman et al., 2017). Thus, which PKA phosphorylation sites and 
what is their precise function in β-AR regulation of the LTCC in cardiomyocytes still 
remain to be established. 
 
1.2.2.2 Regulation via Protein Kinase C induced phosphorylation 
Protein kinase C (PKC) activation is a result of the agonist induced Gq protein coupled 
receptor stimulation, which leads to phospholipase C (PLC) catalysis. The active PLC 
generates inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG) via hydrolysis of 
phosphatidylinositol-4,5-bisphosphate (PIP2), hence induces the PKC activity (Dorn & 
Brown, 1999). In contrast to PKA, PKC has variety of effects on the conductance of 
the LTCC in cardiomyocytes (Lacerda et al., 1988). Phosphorylation of the LTCC by 
    Introduction 
   
15 
 
PKC can either decrease the channel conductance (Satoh, 1995; Zhang et al., 1997) 
or induce it transiently followed by decrease (Lacerda et al., 1988; Tseng & Boyden, 
1991). The cardiac α1C subunit isoform is specifically sensitive to regulation by PKC 
compared to the brain isoform. The reason behind this phenomenon is that the brain 
isoform is missing the first 46 amino acids in the N-terminal tail, which contains two 
crucial amino acid residues, at the position T27 and T31. Mutation of these two 
threonine residues to alanine revealed that the channel is only sensitive to PKC 
modulation when both of these residues are phosphorylated (McHugh et al., 2000). 
 
1.2.2.3 Regulation via calcium/calmodulin dependent serine/threonine kinase II 
induced phosphorylation 
The calcium/calmodulin dependent serine/threonine kinase II (CaMKII) becomes 
activated upon low Ca2+ concentration or β-AR stimulation and induces the LTCC 
phosphorylation (Grimm & Brown, 2010). Two CaMKII phosphorylation sites have 
been identified. One of them is the S1700, which is also the phosphorylation site of the 
PKA. The other one is the threonine 1704 (T1704). To assess the importance of these 
sites in the channel regulation they were mutated to alanine. In the absence of the dCT 
(CaV1.2 ∆1800), neither S1700A nor A1704A had effect on the LTCC current. 
However, in the presence of the dCT (CaV1.2∆1800 + dCT) both mutations decreased 
the channel conductance. These data indicate that basal channel activity depends on 
the phosphorylation of these sites (Fuller et al., 2010). 
 
1.2.2.4 Inactivation by dephosphorylation 
Dephosphorylation of the LTCC is indispensable for its dynamic regulation, since it 
antagonizes the protein kinase mediated phosphorylation (Davare, 2000; Ono & 
Fozzard, 1992; Ono & Fozzard, 1993). It has been demonstrated that Protein 
Phosphatase 1 (PP1), Protein Phosphatase 2A (PP2A), and Protein Phosphatase 2B 
(PP2B) play major role in the channel regulation. PP1 and PKA have opposing action, 
and often share the same substrates (William & Rogers, 2004). Inhibition of PKC 
signaling can be ensured by PP2A (Hansra et al., 1996). However, both PP2A and 
PP2B reverse the PKA mediated phosphorylation (Hall et al., 2006; Tandan et al., 





by PP2A resulting in the decrease of the channel conductance (Hall et al., 2006; Shi 
et al., 2012). 
 
1.2.2.5 Calcium-dependent inactivation  
Many studies have demonstrated that CaM is a crucial mediator of the calcium-
dependent inactivation (CDI) of the LTCC. Three domains on the CT have been 
identified, which play a role in this process; the calcium-binding EF hand, the 
calmodulin-binding isoleucine-glutamine (IQ) motif, and pre-IQ motif (Zühlke & Reuter, 
1998). Upon increment in the intracellular calcium concentration the Ca2+ binds to the 
prebound CaM and accelerates the inactivation of the channel. However, the 
Ca2+/CaM complex can also induce phosphorylation via the CaMKII, hence facilitates 
the channel stimulation indirectly. It has been shown that substitution of the isoleucine 
1624 (I1624), which is the first amino acid in the IQ motif, to alanine (A) I1624A 
removed the CDI and promoted the calcium-dependent facilitation of the LTCC. Using 
CaM mutant (CaM3), which has in three out of four EF-hand alanines instead of 
aspartates, inhibited the CDI and abolished the calcium-dependent facilitation. These 
findings suggest that Ca2+/CaM binding to the IQ motif has pivotal role in CDI, and CaM 
can induce both calcium-dependent inactivation and facilitation of the channel (Zülke 
et al., 1999). 
 
1.3 A Kinase Anchoring Proteins  
It has been shown that only increment in cAMP levels is not sufficient for the proper 
regulation of the PKA substrates (Bers & Ziolo, 2001). The spatiotemporal regulation 
of PKA activation is essential for the effective PKA signaling and is achieved by 
compartmentalization via AKAPs (Manni et al., 2008). At present, there are at least 17 
genes annotated in human genome encoding for AKAPs with as many as 89 different 
isoforms. Despite the poor sequence conservation between the different AKAPs all of 
them share at least two similar functional properties. On one hand, AKAPs are able to 
bind to the docking and dimerization domain (D/D) of the regulatory subunit of PKA via 
a conserved amphipathic helix of 14-18 amino acids (Gold et al., 2006). On the other 
hand, AKAPs contain specific targeting motifs that direct the AKAPs to structural 
elements or membranes, which ensure the subcellular localization of the PKA. Based 
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on their interaction with type-I or type-II PKA regulatory subunit, they are divided into 
three groups. AKAPs, which only associate with either type-I or type-II, and dual 
specific AKAPs, which interact with both type of regulatory PKA subunit (Jarnaess et 
al., 2008). In addition, AKAPs form multivalent signaling complexes by anchoring 
simultaneously their specific-bound kinases and phosphatases. 
 
1.3.1 AKAPs in cardiomyocytes  
Over the past decades many AKAPs have been identified in cardiomyocytes. For 
instance the AKAP18α, AKAP18δ, AKAP79, AKAP250, Yatio, mAKAP, AKAP-Lbc, 
AKAP220, dual specific D-AKAP-1 and -2, AKAP95, Synemin, Ezrin, Gravin, Myosprin 
and Troponin T (Diviani et al., 2011). Each of these AKAPs target PKA signaling to 
different subcellular compartments, thereby ensuring the specificity and increasing the 
efficiency of the PKA substrates phosphorylation. Most of these AKAPs are also 
associated with proteins, which regulate calcium fluxes. mAKAP is involved in 
regulation of RyR2 (Marx et al., 2000). Gravin regulates the desensitization of the β2-
AR (Fan et al., 2001). Akap18δ regulates the calcium re-uptake into the SR by forming 
a supramolecular complex with SERCA and PLN (Lygren et al., 2007). Furthermore, 
AKAP79 (AKAP150/AKAP5) and AKAP18 (AKAP15/AKAP7) were identified as crucial 
regulators of LTCC conductance (Gao et al., 1997; Gray et al., 1998). Hence, AKAPs 
are indispensable in a range of cellular events; in cardiomyocytes specifically 
coordinating action potential duration and cardiac contraction. 
 
1.3.2 LTCC regulation via AKAP5 
In attempt to unify the nomenclature of AKAP protein family, gene name is used 
throughout the study instead of protein name; for example, AKAP5 is used instead of 
AKAP79/150 (the human AKAP79 is the homologue of mouse/rat AKAP150 that are 
encoded by the AKAP5 gene). The AKAP5 is a membrane targeted scaffold protein, 
which binds to PKA, PKC, PP2B, N-methyl-D-aspartate receptor, α-amino-3-hyrdoxy-
5-methyl-4-isoxazolepropionic receptor, Synapse-associated protein-97 (SAP97), 
aquaporin water channel, and LTCC (Wong & Scott, 2004). It contains at its N-terminal 
tail the PKC binding domain (aa 31-52) and PP2B binding domain (aa 81-102), and at 





(Klauck et al., 1996). AKAP5 binds to the LTCC via modified Leucine-Zipper (LZ) motif, 
which are heptad-spaced hydrophobic residues in the C-terminus after the RII-binding 
domain (Oliveria et al., 2007). 
Overexpression of AKAP5 induces the channel activity by promoting the 
phosphorylation by PKA (Gao et al., 1997). In neurons, the targeting of PKA and PP2B 
simultaneously by AKAP5 enables a bidirectional regulation of the LTCC (Oliveria et 
al., 2007). Overexpression of AKAP5 in the presence of HT31 peptide, which disrupts 
the AKAP-PKA interaction, upon β-AR stimulation reduced the channel activity 
(Oliveria et al., 2007). However, overexpression of AKAP5 mutant that lacks the PP2B 
binding motif (PXIXIT) in the presence of HT31 peptide, had no effect on the channel 
conductance, suggesting that AKAP5 targeted dephosphorylation by PP2B is required 
for the channel regulation (Oliveria et al., 2007). Using LTCC inhibitor, it has been 
shown that LTCC activation is required for the nuclear factor of activated T cells (NFAT) 
nuclear translocation. The NFAT translocation into the nucleus was abolished in 
neurons where the AKAP5 was downregulated or AKAP5 was lacking the PXIXIT 
motif. These findings suggest that PP2B anchoring by AKAP5 to the LTCC regulates 
NFAT signaling (Oliveria et al., 2007). Furthermore, it has been shown in HEK293 cells 
that AKAP5 targeted PKA phosphorylation mediates the recycling and resensitization 
of the β1-AR (Gardner et al., 2006). The phosphorylation of the β1-AR by PKA is 
ensured by SAP97, which targets the AKAP5-PKA complex to the receptor (Gardner 
et al., 2007). This role of AKAP5 was also confirmed in cardiomyocytes using neonatal 
AKAP5 mutant mice (Li et al., 2013), indicating an indirect effect of AKAP5 in the LTCC 
regulation. Nevertheless, β-AR stimulation efficiently increased LTCC current in the 
AKAP5 knockout (KO) adult cardiomyocytes (Nichols et al., 2010), suggesting that 
AKAP5 is dispensable for this process. 
 
1.3.3 LTCC regulation via AKAP7  
AKAP15 and AKAP18 were named after their protein size, however they are encoded 
by the same gene called AKAP7 (Gray et al., 1998). AKAP7α and AKAP7β are the 
short isoforms (AKAP15), while AKAP7γ and AKAP7δ are the long isoforms (AKAP18) 
(Trotter et al., 1999). AKAP7 forms multivalent signaling complexes with PKA, voltage-
-gated calcium channels, voltage-gated sodium channels (Wong & Scott, 2004), and 
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with PKC (Redden et al., 2012). Previous study showed that AKAP7α directly interacts 
with the ABD of the α1C subunit via modified LZ motif, because either mutation in the 
LZ motif or in the ABD abolished their interaction. Furthermore, cardiomyocytes 
transfected with a competing peptide, which specifically blocks the interaction between 
AKAP7 and the α1C subunit, had modest increment in the LTCC conductance upon 
β-AR stimulation (Hulme et al.,2003). 
It has been shown by Fuller and his colleagues that overexpression of the α1C subunit 
without the dCT (CaV1.2∆1800) upon β-AR stimulation greatly increases the channel 
activity. In contrast, coexpression of the CaV1.2∆1800 together with a dCT construct 
abolishes the channel activity, which supports the autoinhibitory function of the dCT. 
However, coexpression of both constructs with AKAP7 relieves the inhibition of the 
dCT via phosphorylation of the S1700, hence induces the LTCC conductance (Fuller 
et al., 2010). Surprisingly, coexpression of these constructs with AKAP5 upon β-AR 
stimulation had no effect on the channel activity, which indicates differences between 
the two AKAPs in the channel regulation. However, coexpression of CaV1.2∆1800, 
dCT and AKAP5 mutant which lacks the PXIXIT motif upon β-AR stimulation enhanced 
the channel activity (Fuller et al., 2014). These experiments indicate that the functional 
differences between AKAP5 and AKAP7 in the channel regulation are based on their 
ability to form multivalent signaling complexes. Furthermore, both AKAPs bind to the 
same modified LZ motif on the CT, which indicates potential competition between 
them. Hence, depending on which AKAP can bind to the channel, offers an additional 
regulatory layer in the LTCC regulation. 
Western blot and qPCR analysis using AKAP7 KO murine heart lysates revealed that 
the short AKAP7 isoforms (AKAP7α/β) are not present in cardiomyocytes (Jones et al., 
2012). In addition, measuring the channel conductance upon β-AR stimulation in 
AKAP7 KO cardiomyocytes showed similar increment as in the wild-type cells. The 
same effect was documented in AKAP5/AKAP7 double KO cardiomyocytes (Jones et 
al., 2012). These results suggest that AKAP5 and AKAP7 are not indispensable in their 







1.4 Wnt signaling 
The Wnt signaling is an evolutionary conserved pathway within metazoan animals and 
regulates crucial aspects of development. It determines cell fate and polarity and 
regulates proliferation, migration and organogenesis during embryonic development. 
At present, 19 WNT genes have been identified and classified into 12 subfamilies. The 
Wnt ligands are secreted glycoproteins, which are divided into two major groups 
dependent on their ability to induce β-catenin dependent signaling. Based on this we 
distinguish between canonical (β-catenin dependent) and non-canonical (β-catenin 
independent) Wnt signaling. However, which signaling pathway becomes active is not 
exclusively dependent on the WNT proteins, but also on their receptors Frizzled (FZD), 
and their co-receptors: the low-density lipoprotein receptor related protein 5/6 
(LRP5/6), tyrosine kinase-like orphan receptor (Ror2) and receptor-like tyrosine kinase 
(Ryk) (Hendrickx & Leyns, 2008; Schulte, 2015).  
The Wnt canonical signaling is activated upon binding of either WNT1, WNT3A, 
WNT5A, WNT6, WNT7B and WNT8A (Jiang et al., 2017; Katoh, 2002; Posokhova et 
al., 2015; Dawson et al., 2013) to FZD and to LRP5/6, which triggers the Dishevelled 
(DVL) recruitment to the membrane. These events result in Axin being targeted to 
LRP5/6, and subsequent disassembly of the β-catenin destruction complex that 
includes Axin, Adenomatosis polyposis coli (APC), Glycogen synthase kinase 3β 
(GSK3β) and Casein kinase 1α (CK1α). This leads to β-catenin stabilization, 
accumulation in the cytoplasm, and translocation into the nucleus, where it associates 
with the TCF/LEF transcription factor (Gordon & Nusse, 2006; Pandur et al., 2002) 
(Figure 3A). 
The Wnt non-canonical pathway regulates cell polarity, migration and convergent-
extension movements (Veeman et al., 2003). It can be further divided into two groups. 
The Planar Cell Polarity pathway (PCP) is activated upon binding of either WNT2, 
WNT4, WNT5A, WNT7A, WNT11 or WNT16 (Chen et al., 2018; Nalesso et al., 2017; 
Dawson et al., 2013) to the FZD, however, the downstream signaling does not require 
LRP5/6 (He et al., 2004). Activation of FZD recruits DVL to the membrane, which 
initiates two signaling events. One of the branches is activated upon DVL binding to 
Dishevelled associated activator of morphogenesis 1 (Daam1), which leads to the Rho-
associated kinase (ROCK) activation via Rho GTPase. The other branch of the 
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signaling is independent from Daam1 and stimulates c-Jun N-terminal kinase (JNK) 
via Rac GTPase (He et al., 2004; Pandur, Maurus, et al., 2002) (Figure 3B). 
The second branch of the Wnt non-canonical signaling is the Wnt/Calcium pathway, 
which increases the intracellular calcium. It has been shown that this increase may 
occur through pertussis toxin-sensitive Gi protein; upon FZD2 stimulation with WNT5A 
the PLC levels increased, however treatment with pertussis toxin abolished the PLC 
increment. This results imply that the FZD activation resulted in the Gα dissociation 
from the Gβγ subunits, and induced the PLC activation (Slusarski et al., 1997). The 
catalysis of PLC induces the conversion of the PIP2 into IP3 and DAG, which together 
with the increased intracellular calcium concentration stimulate calcium sensitive 
proteins like CaMKII, PP2B and PKC (Dorn & Brown, 1999). In accordance, the FZD2 
activation stimulated the CaMKII and the PKC signaling in a pertussis toxin-dependent 
manner (Kühl et al., 2000; Li et al., 1999). Furthermore, stimulation of the Wnt/Calcium 
pathway induced NFAT signaling, which was cancelled by using PP2B blocker 
suggesting that Wnt/Calcium pathway regulates NFAT signaling on PP2B dependent 
manner (Saneyoshi et al., 2002). In addition, the Wnt/Calcium pathway can antagonize 
the canonical Wnt signaling via stimulation of the NFAT signaling (Saneyoshi et al., 
2002). Overexpression of Gi rescued the Wnt signaling in FZD2-deficient drosophila 
embryos, which strengthened the observation that FZD2 may signal through Gi protein 















1.4.1 Frizzled receptor couples with G proteins  
The seven transmembrane (7TM) receptors belong to the largest membrane receptor 
family, which includes over 800 genes. These genes encode receptors for hormones, 
neurotransmitters, chemokines, photoreceptors and sensory receptors. The common 
feature of these receptors is that they are composed of seven helices of hydrophobic 
amino acids and couple with heterotrimeric G proteins, therefore they are also called 
GPCRs. Based on their sequence similarities GPCRs are divided into three groups. 
Photoreceptors and adrenergic receptors belong to class A, receptors like vasopressin 
Figure 3: Three main branches of Wnt signaling. (A) Wnt canonical signaling. Wnt 
induces the disruption of the β-catenin (β-Cat) destruction complex, hence it activates the 
β-catenin dependent gene transcription. (B-C) Wnt non-canonical pathways. (B) Planar cell 
polarity (PCP) signaling. Stimulation of PCP leads to the activation of the Rho-associated 
kinase (ROCK) and c-Jun N-terminal kinase (JNK). (C) Activation of Wnt/Calcium signaling 
increases intracellular calcium level via Phospholipase C (PLC) catalysis, hence it induces 
Protein kinase C (PKC), Protein Phosphatase 2B (PP2B) and Ca2+/Calmodulin-dependent 
kinase (CaMKII) signaling. FZD- Frizzled, DVL- Dishevelled, LRP5/6- Low-density 
lipoprotein related protein 5/6, APC- Adenomatosis polyposis coli, GSK3β- Glycogen 
synthase kinase 3β, CK1- Casein kinase 1, Daam1- Dishevelled associated activator of 
morphogenesis 1, Gαi subunit- αI, Gβ subunit- β,  Gγ subunit- γ, IP3- inositol-1,4,5-
triphosphate, DAG- Diacylglycerol, EC- extracellular, IC- intracellular. 
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receptors and parathyroid hormone receptors belong to class B, while class C includes 
the metabotropic glutamate receptor family (Pierce et al., 2002). 
Upon agonist stimulation of the GPCR, it interacts with the heterotrimeric G proteins 
and induces guanine diphosphate exchange to guanine triphosphate, leading to the 
dissociation of the Gα subunit from the Gβγ (Gilman, 1987). This initiates variety of 
signaling events dependent on the Gα subunit. The Gα subunits can be divided into 
four main groups. The Gs protein induces AC activity, while the Gi protein has the 
opposite effect, since it inhibits the AC activation. The Gq protein stimulates PLC, and 
the G12/13 protein induces Rho activation (Pierce et al., 2002). 
At present, 10 FZD homologues have been identified, which belong to the 7TM 
receptor family. Despite of the similarities in their structure to other GPCRs, these 
proteins were separately grouped together with smoothened proteins (Foord et al., 
2005). This discrimination is based on that their N-terminal tail consists of a unique 
cysteine rich domain, which enables them to bind the WNT ligands. Furthermore, FZD 
lacks DRY motif on its C-terminal tail, which is known to be important for G protein 
coupling (Schulte, 2010). However, there is an increasing evidence that the FZDs 
signal through heterotrimeric G proteins (Schulte & Bryja, 2007). 
The first indications that G protein couples to FZD were obtained using pertussis toxin, 
where the increased PKC signaling via FZD2 stimulation was abolished by inhibition 
of the Gi protein (Slusarski et al., 1997). Investigation, whether other G proteins couple 
to FZD and influence the PKC signaling revealed that some (FZD3, FZD4, FZD6), but 
not all (FZD7, FZD8) regulates PKC stimulation via Gi protein dependent mechanism 
(Sheldahl et al., 1999). Since then only few studies investigated the interaction 
between FZDs and G protein system. One of the studies is provided by Nichols and 
her colleagues, who have demonstrated the signaling between different FZDs and G 
proteins using WNT8-FZD chimeras. The yeast strains that had either Gs, Gi or Gq 
chimeras were transformed with either WNT8-FZD1, WNT8-FZD2, WNT8-FZD6 or 
WNT8-FZD7 chimeras. In contrast with the expectations all WNT8-FZD chimeras did 
preferentially interact with Gs over Gi or Gq (Nichols et al., 2013). In accordance with 
this, it has been demonstrated that WNT7A induced FZD7 signaling through Gs protein. 
This observation was confirmed by mass spectrometry analysis using C2C12 cells, 





1.4.2 Wnt11 non-canonical signaling 
The Wnt11 non-canonical pathway promotes ventral cell fate via NFAT signaling 
induction (Saneyoshi et al., 2002). It controls cell contact persistence (Witzel et al., 
2006), anterior-posterior axis elongation, and convergent-extension movements 
(Heisenberg et al., 2000; Kim et al., 2008). In addition, almost two decades ago Wnt11 
has been identified as a key regulator in cardiac development (Eisenberg & Eisenberg, 
1999).  
Using Xenopus embryos, it has been shown that wnt11 and fzd7 have significant 
overlapping expression in the marginal zone of early gastrula. In addition, Wnt11 
synergized with Fzd7 to inhibit gastrulation movements. Co-immunoprecipitation 
experiment revealed that the myc-tagged Wnt11 binds to ectopically expressed Fzd7. 
These data indicate that the putative receptor of WNT11 is the FZD7 (Djiane et al., 
2000). 
Morpholino gene knockdown (KD) of wnt11 in Xenopus embryo revealed that Wnt11 
induces early cardiac gene expression (like nkx2.5, gata4, tbx5) required for the normal 
cardiac differentiation. Since WNT11 acts through Wnt non-canonical pathway, it 
raised the question, whether the downstream components are involved in the 
regulation of cardiac gene expression. Treatment of the wnt11 morphants with either 
CaMKII, PKC or JNK revealed that none of them could restore the gene expression. 
However, activation of both PKC and JNK signaling rescued the gene expression, 
which imply that both Wnt/Calcium and PCP pathways are important during early 
cardiogenesis (Pandur, Lasche et al., 2002). Furthermore, Wnt11 signaling together 
with the Wnt canonical signaling are required for the second heart field formation. This 
result was obtained from differentiating embryonic stem cells, where WNT11 induced 
the cardiac progenitor development by antagonizing the Wnt canonical pathway 
(Cohen et al., 2012). 
The present study is based on the finding of Panáková and her colleagues, who have 
demonstrated that loss of Wnt11 signaling results in homogenous conduction velocities 
all over the developing zebrafish ventricle. Investigation whether the Wnt11/PCP 
pathway contributes to the electrical gradient patterning, revealed that neither loss of 
Vangl2 nor Prickle1, which are the core components of the PCP pathway, perturbed 
the gradient, suggesting that PCP is dispensable for this process. However, the 
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absence of Wnt11 increased the transient amplitude of intracellular Ca2+ concentration 
([Ca2+]i) all over the ventricle. Similarly, stimulation of the LTCC activity increased the 
[Ca2+]i transient amplitude as loss of Wnt11 did, which implied that Wnt11 might 
regulate the electrical gradient formation by attenuating the Ca2+ influx through the 
LTCC. Injection of cacna1c mutant embryos with wnt11 morpholino resembled the 
wild-type conduction phenotype, suggesting that Wnt11 indeed regulates myocardial 
electrical formation upstream of the LTCC. In addition, loss of Wnt11 enhanced 
Connexin 43 (Cx43) levels, which were restored in the absence of WNT11 and the 
LTCC, which strengthened the idea that WNT11 acts upstream of LTCC (Panáková et 






Figure 4: Schematic representation of Wnt11/Calcium signaling in cardiomyocytes. 
In developing zebrafish ventricle Wnt11 regulates the electrical gradient formation via 
attenuation of the LTCC conductance. LTCC- L-type calcium channel, NCX- Na+/Ca2+ 
exchanger, RyR2- Ryanodine receptor 2, SERCA- Sarcoplasmic Reticulum Ca2+-ATPase, 
PLN- Phospholamban, DVL-Dishevelled, FZD7- Frizzled 7, GαI subunit- αI, Gβ subunit- β,  





1.5 L-type calcium channel in cardiac disease 
The LTCC ensures predominant route for calcium entry into the cells, which shapes 
the action potential and induces E-C coupling. Furthermore, the calcium can induce 
many signaling transduction pathways, which have a pivotal role regulating the growth 
response in the heart. These hypertrophic pathways include the PP2B/NFAT 
(Molkentin et al., 1998) and PKC/CaMKII regulated histone deacetylase (HDAC) 
pathways (Vega et al., 2004). Cardiac hypertrophy leads to arrhythmia and congestive 
heart failure, and eventually to sudden cardiac death. Thus, abnormalities in LTCC 
functions have implication for cardiac output. 
It has been shown that in the failing human ventricular myocytes (F-HVM) the base 
line phosphorylation, the open probability (Po) and availability of a single LTCC was 
increased, hence the single channel current (iCa) (Schröder et al., 1998). Furthermore, 
many studies demonstrated the downregulation of LTCC in patients with atrial 
fibrillation (AF) (Brundel et al., 2001; Lai et al., 1999). Similarly, to these observations, 
decreased channel density (N) was documented in F-HVM concomitant with unaltered 
basal calcium current (ICa) density (Chen et al., 2002). In accordance with the previous 
finding, these data suggested that in F-HVM the basal calcium current density is 
maintained by increased open probability of the LTCC (ICa=N · Po · iCa) (Chen et al., 
2002). However, the studies investigating the LTCC abundance in patients with heart 
diseases are not always congruent. It has been also shown in human patients with 
chronic AF that the LTCC abundance was unaltered (Schotten et al., 2003). The 
linkage between LTCC and hypertrophy was strengthened when application of 
diltiazem (LTCC inhibitor) rescued the cardiomyopathy in mice, which carry an 
Arg403Gln missense mutation in one allele of the cardiac myosin heavy chain 
αMHC403/+ (Semsarian et al., 2002), although the underlying molecular mechanisms 
remained unclear. Despite of these results, clinical trials using calcium channel 
blockers (CCBs) for heart failure had disappointing effects. More recent study was 
investigating the outcome of the usage of CCBs in older patients with heart failure with 
preserved ejection fraction. They have documented that application of CCBs had no 
association with the end points of the mortality or heart failure hospitalization in these 
patients (Patel et al., 2014). 
Besides the dysfunction of the LTCC, mutations in the CACNA1C gene can also lead 
to congenital heart disease. A novel long QT arrhythmia syndrome associated with 
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syndactyly was described already in the middle of the 90ties. (Marks et al., 1995). 
Almost 10 years later Splawksi and his colleagues have identified in patient with the 
aforementioned syndromes two de novo point mutations in the CACNA1C gene, which 
were caused by substitution of glycine with arginine at residue 406 (G406R) and 
glycine with serine G402S. These mutations result in multisystem disorder, called 
Timothy syndrome (TS), including arrhythmia disorder associated with dysfunction in 
multiple organ systems, congenital heart disease, syndactyly, immune deficiency and 
autism (Splawski et al., 2004; Splawski et al., 2005). Further studies also discussed 
the relevance of AKAP5/LTCC interaction in TS. AKAP5 is stabilized in the open 
conformation of the mutant LTCC, hence facilitated Ca2+ influx, which eventually 
resulted in sudden cardiac death. However, ablation of the AKAP5 rescued the gating 
in mutant LTCC and protected the heart from arrhythmias (Cheng et al., 2011; Dixon 
et al., 2012). 
To develop more effective and specific treatments, it is crucial to improve our 
understanding of how the LTCC is regulated. It needs to be better defined, which 
signaling pathways are involved in the channel activation or inhibition, and which 

















2 Aims of the Thesis 
Although the compartmentalized PKA activity via the β-AR systems and its effect in the 
L-type calcium channel regulation was demonstrated over the past few decades, little 
attention has been paid to the regulation via alternative GPCR-like systems such as 
the Wnt11 non-canonical pathway. The observation that Wnt11 regulates the LTCC in 
developing zebrafish heart (Panáková et al., 2010) brought novel insights into our 
understanding of the interactions between signaling pathways and ionic cues in the 
epithelial biology and organ development, and opened a new area of research with 
many questions remained to be answered. How does Wnt11 modulate the LTCC 
function? Is the interaction between Wnt11 and LTCC direct or indirect? Is Wnt11 
affecting the expression levels of the LTCC or modulating the channel function post-
translationally? 
This study set out to explore the molecular mechanisms that lead to the attenuation of 
LTCC conductance by non-canonical Wnt11 signaling, and how this machinery affects 
the intercellular electrical coupling and cardiac function. The specific aims of the 
presented study were: 
• Determine whether Wnt11 regulates the expression and/or localization of the 
LTCC.  
• Identify the core components downstream of the Wnt11/Calcium pathway in the 
regulation of the LTCC. 
• Analyze whether the identified downstream components contribute to the 
establishment of the myocardial electrical gradient in developing zebrafish 
heart. 
This study not only improves our understanding of fundamental role of Wnt11 in 
regulating LTCC function, but also brings new insights into basic cardiac biology as 
well as pathophysiology of common cardiovascular diseases such as arrhythmias and 
sudden cardiac death. 
 
 
           Results 





3.1 Establishment of cell based model to study Wnt11-LTCC 
interaction
To study Wnt11-LTCC interaction I utilized rat heart-derived myoblast cell line H9c2. 
Although H9c2 cells are not able to beat spontaneously, these cells have the 
advantage of being immortalized and animal-free alternative to study transmembrane 
signal transduction in cardiomyocytes. In these cells, the LTCC shows the classical 
characteristics of being sensitive to dihydropyridines and its open probability can be 
enhanced by isoproterenol (ISO) (Hescheler et al., 1991). Furthermore, in vitro study 
demonstrated that they show similar hypertrophic response as neonatal rat ventricular 
myocytes (NRVMs) (Watkins et al., 2011). First, I had to establish applicability of 
studying the molecular Wnt11-LTCC interaction in this cell model. I showed in 
collaboration with Dr. Tareck Rharass that the components of the Wnt11 signaling 
pathway including WNT11, its putative receptor FZD7, DVL1/2/3 and β-CAT are 
expressed in H9c2 cells. I also confirmed the expression of the CACNA1C gene, which 
encodes the α1C subunit of the channel, which is in line with published data 
investigating the electrophysiological properties of H9c2 cells (Hescheler et al., 1991). 
Furthermore, I showed that these cells are expressing TROPONIN-T (TPM), which 
confers calcium sensitivity, and MYOGENIN (MYOG), which is a typical muscle-
specific transcription factor (Figure 5A). It has been shown by Panáková and her 
colleagues that the absence of wnt11 results in increment in Connexin 43 (Cx43) levels 
in developing zebrafish embryos (Panáková et al., 2010). To confirm this observation 
in H9c2 cells, first the efficiency of the WNT11 KD was corroborated using siRNA 
(Figure S1A). Next, immunoblotting of the lysates of untreated and WNT11 siRNA 
transfected cells was performed (Figure 5B). Quantification of the CX43 amount in 
comparison to β-ACTIN amount showed that loss of WNT11 leads to increased levels 
of CX43 in a similar fashion as in zebrafish embryonic hearts (Figure 5C). Taken 
together, the H9c2 cells express all the necessary components of the Wnt11 signaling 
and react similarly to the reduced levels of WNT11 as zebrafish embryonic hearts 














3.2 Wnt11 signaling prevents the CT from proteolytic processing 
 
3.2.1 Wnt11 signaling does not alter LTCC, but dCT expression 
As aforementioned, the CT isoforms (75 kDa, 40 kDa) of the α1C subunit can 
translocate into the nucleus, where they act as a TF or co-factors (Gomez-Ospina et 
al., 2006; Schroder et al., 2009). Furthermore, in brain tissue there is another dCT 
isoform (15 kDa), which can be translated from an independent transcript generated 
from a cryptic promoter (in exon 46 in murine gene) (Gomez-Ospina et al., 2013). This 
isoform is also able to translocate into the nucleus and act as a TF (Gomez-Ospina et 
al., 2013). In the light of these facts, to elucidate whether Wnt11 signaling affects the 
expression of the different isoforms of the α1C subunit, I used three distinct TaqMan 
probes targeting exon 18, 39 and 45 of the CACNA1C gene. These targeting sites 
correspond to II-III loop, proximal-CT (pCT) and distal-CT (dCT) of the α1C subunit as 
Figure 5: H9c2 cells are a suitable model to study Wnt11-LTCC interaction. (A) RT-
PCR of cDNA of the indicated genes. (B) Western blot (WB) analysis of Connexin 43 (Cx43) 
in lysates of untreated control (U) and WNT11 siRNA transfected (W) H9c2 cells. Cx43 was 
detected using anti-Cx43 antibody; the membrane was re-stained with anti-β-actin 
antibody. ROIs delimited with dashed line show relative mobility of Cx43 (left) and β-actin 
(right). C) Column graph displays the Cx43 protein levels that were normalized to β-actin. 
(Mean ± SD; N = 2). FZD-Frizzled; DVL- Dishevelled; β-CAT-β-Catenin; TPM- Troponin T, 
MYOG- Myogenin, GAPDH- Glyceraldehyde 3-phosphate dehydrogenase. 
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it is represented in Figure 6A. Of note, the rat CACNA1C (ENSRNOT00000052017.6) 
exon 45 is identical with mouse (ENSMUST00000186889.6) exon 47. Using 
CACNA1C siRNA the specificity of the TaqMan probes were validated (Figure S1A). 
qPCR analysis revealed that downregulation of WNT11 have effect neither on the 
LTCC nor on the CT expression levels. However, the expression of the dCT is slightly 











3.2.2 Wnt11 has no effect on the localization or abundance of LTCC 
To investigate whether Wnt11 regulates the LTCC on the protein level, I performed 
immunostaining experiments in collaboration with Dr. Tareck Rharass. First, I used an 
anti-II-III-loop antibody, which recognizes the intracellular loop between 
transmembrane II and III domains of the α1C subunit (Figure 7).  
Figure 6: Wnt11 signaling does not alter LTCC, but dCT expression. (A) Schematic 
representation of the rat LTCC complex with the highlighted sites for the TaqMan probes 
on the α1C subunit (ENSRNOT00000052017.6). EC- extracellular, IC- Intracellular (B) 
Relative mRNA expression of CACNA1C gene was measured in Scramble or WNT11 
siRNA transfected H9c2 cell via quantitative RT-PCR and normalized to the relative mRNA 
expression of GAPDH in Scramble siRNA transfected cells. Data represent the fold 
change of log2 (2^-∆∆Ct) of the interested genes. (Mean ± SD of N = 3 experiments;             
ns P(CACNA1C exon 18)=0.4258; ns P(CACNA1C exon 39)=0.4258; *P(CACNA1C exon 







The localization of the α1C subunit was unaltered in the transfected cells either with 
Scramble (Figure S2A) or with WNT11 siRNA (Figure 8A) compared to the untreated 
cells. In these cases, the α1C subunit showed exclusively membrane and cytoplasmic 
localization. Transfecting the cells with CACNA1C siRNA reduced the protein levels of 
the α1C subunit compared to untreated cells (Figure S2A) corroborating the specificity 








Figure 8: Wnt11 has no effect on the localization or abundance of the LTCC. (A) 
Maximum intensity projection of confocal images of untreated and WNT11 siRNA 
transfected H9c2 cells, immunostained with anti-II-III-loop (Millipore) (gray/green), anti-F-
actin (gray) antibodies, and DAPI (blue). (N ≥ 3 experiments; n ≥ 110) (B) Quantification of 
mean intensity of II-III-loop antibody in the whole cell. Data of column graphs expressed as 
mean ± SD of N ≥ 3 experiments and n ≥ 110 (ns P =0.2443; Welch’s t test) as it is 
represented in the columns. Frequency distribution plot demonstrates the percentage of the 
cell population with the corresponding mean intensity. The scale bar represents 20 µm. 
 
Figure 7: Binding sites of the 
antibodies on the α1C subunit. 
Schematic representation of the rat 
LTCC complex with the binding sites 
of the anti-II-II-loop and anti-pCt 
antibodies on the α1C subunit. EC- 
extracellular, IC- Intracellular. 
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Measuring the fluorescent intensity of the II-III-loop antibody staining in the whole cell 
using the F-actin staining as a mask revealed that the channel abundance is similar in 
untreated compared to WNT11 KD cells (Figure 8B). This result is in line with the qPCR 
data, since Wnt11 had no effect on the expression of transmembrane pore-forming 
isoform. These data suggest that in H9c2 cells the α1C subunit localization and 
abundance is independent of Wnt11 signaling. 
 
3.2.3 Wnt11 signaling regulates the formation of the CT isoform 
To determine the CT localization within the cells I used, in collaboration with Dr. Tareck 
Rharass, anti-pCt antibody, which showed specificity in recognition of the α1C subunit 
(Figure S2B). This antibody recognizes the pCT, therefore it detects the full-length α1C 
subunit as well as the cleaved CT isoform, but not the dCT fragment (Figure 7). In 
contrast to the II-III loop antibody in untreated cells the signal appeared also in the 
nucleus. Surprisingly, downregulation of Wnt11 signaling pathway achieved with 
WNT11 or FZD7 siRNA treatment led to enhanced nuclear localization of the CT 
fragment (Figure 9A), in which cases the intensity of the pCt staining increased by 71% 
in the absence of WNT11 (Figure 9C) and by 43% in the absence of FZD7 (Figure 9D) 
compared to untreated cells. Throughout the whole nucleus CT formed punctate 
pattern as it has been previously shown (Gomez-Ospina et al., 2006), and in addition 
it accumulated in 2 to 3 bigger punctae per cell. Co-staining with nucleolin antibody 
(anti-Nuc) revealed that the loss of Wnt11 signaling specifically induced the CT isoform 
localization in the nucleoli (Figure 9B). Although this phenomenon has also occurred 
in untreated cells, the reduction of Wnt11 signaling led to significant increase and more 
homogeneous cell population regarding the CT localization in the nuclei compared to 
untreated cells. The frequency distribution plots show clearly that higher percentage of 
cell population has increased accumulation of pCt in the nucleoli. Since in the absence 
of WNT11 I could not detect any differences in the mRNA expression levels of the CT, 
but clear changes occurred in the CT localization within the cells compared to 
untreated cells suggesting that Wnt11 regulates the cleavage of the CT. The fact that 
loss of Wnt11 signaling was inducing the CT nuclear localization indicates that Wnt11 












3.3 AKAP anchored PKA signaling regulates the CT formation 
downstream of Wnt11 pathway 
 
3.3.1 PKA signaling stimulation leads to the CT isoform generation 
Over the past few decades many studies have demonstrated that β-AR/Gs protein 
signaling regulates the LTCC activity through the post-translational modification of the 
dCT of the α1C (Fu et al., 2011; Ganesan et al., 2006), but our understanding of the 
regulation of the CT isoform via this pathway remains incomplete. To examine the role 
of the β-AR/Gs system in the CT isoform formation, the cells were exposed to β-AR 
pathway agonist, isoproterenol (ISO) treatment for 3 minutes prior to fixation. Induction 
of this pathway enhanced the CT isoform generation (pCt intensity increased in the 
nucleoli by 48%) in a similar fashion as the loss of Wnt11 pathway did (Figure 10A and 
Figure 9: Wnt11 signaling regulates the formation of the CT isoform. (A) Maximum 
intensity projection of confocal images of untreated, WNT11 or FZD7 siRNA transfected 
H9c2 cells immunostained with commercially available anti-pCt (Abnova) (gray/magenta) 
and anti-Nuc (green). (N ≥ 3 experiments; n ≥ 100). (B) Line-scan analysis of pCt and 
nucleolin staining intensities in the nucleus. (C-D) Quantification of mean intensity of pCt 
antibody in nucleoli of H9c2 cells. Data of column graphs expressed as mean ± SD of N ≥ 
3 experiments and n ≥ 100 (****P<0.0001; Welch’s t test). Frequency distribution plots 
demonstrate the percentage of the cell population with the corresponding mean intensity. 
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10B). The stimulation of β-AR pathway subsequently induces the phosphorylation of 
the LTCC by increasing local PKA activity, and leads to the dCT isoform generation 








To explore whether PKA activity affects the CT generation, the cells were treated with 
PKA agonist, Forskolin (FSK) at 10 µM concentration for 1 hour. The FSK exposed 
cells showed increment in phosphorylated PKA substrates amount compared to 
untreated cells (Figure 11) as well in the pCt intensity (increased by 101%) (Figure 10A 
and 10C). These data indicate that β-AR induced PKA signaling regulates the cleavage 
of the CT. 
Figure 10: PKA signaling stimulation leads to the CT isoform generation. (A) Maximum 
intensity projection of confocal images of H9c2 cells immunostained with anti-pCt (Abnova) 
(gray/magenta) and anti-Nuc (green). Cells were treated with 4 µM ISO for 3 minutes or 
with 10 µM FSK for 1 hour.  (N ≥ 3 experiments; n ≥ 85). (B-C) Quantification of mean 
intensity of pCt antibody in nucleoli of H9c2 cells. Data of column graphs expressed as 
mean ± SD of N ≥ 3 experiments and n ≥ 85 (****P <0.0001; Welch’s t test). Frequency 
distribution plots demonstrate the percentage of the cell population with the corresponding 










3.3.2 Wnt11 signaling regulates the CT isoform generation via AKAP anchored 
PKA signaling 
The next question was whether there is an interaction between PKA and Wnt11 
signaling in the regulation of the CT formation. To address this question, I used Protein 
kinase inhibitor (PKI) peptide (a gift from PD Dr. Enno Klußmann). PKI can specifically 
inhibit the free catalytic subunit of the PKA, hence obstructs the phosphorylation of the 
PKA substrates (Figure 11). Compared to cells with the reduced Wnt11 signaling, in 
cells treated with 10 µM PKI for 1 hour with the simultaneous WNT11 siRNA treatment, 
the CT isoform formation was reduced to basal levels (pCt intensity only increased by 
9%). The phenotype of these cells regarding the CT formation was very similar to the 
untreated cells (Figure 12A and 12B). 
It has been shown that AKAP proteins play important role in the LTCC regulation, since 
they regulate local PKA activity by anchoring the PKA to its substrates. To investigate 
AKAP anchored PKA signaling in the CT formation the cells were treated with L314E 
peptide (a gift from PD Dr. Enno Klußmann). This membrane-permeable peptide is a 
general AKAP inhibitor due to its ability to abolish the interaction between the PKA 
regulatory subunit and any AKAP (Figure 11) (Hundsrucker et al., 2006). Cells treated 
with 100 µM L314E for 1 hour, in the absence of Wnt11 signaling partially rescued the 
loss of WNT11 phenotype. Although cells still showed slight increment in pCt intensity 
(pCt only increased with 13%) in comparison to untreated cell (Figure 12A and 12C), 
Figure 11: Phosphorylation levels of the PKA substrates upon drug treatment. (A) 
Western blot (WB) analysis of phosphorylated PKA substrates in lysate of untreated control 
(Unt) and of FSK, PKI or L314E treated H9c2 cells by using anti-pPKA substrate antibody. 
Below, cell lysate lanes were run on the same gel, but the membrane was cut as it is 
indicated by the gap and developed with β-actin. (B) Column graph represent the 
phosphorylated PKA substrates amount, which was normalized to β-actin amount. (N ≥ 2 
experiments). 
 
           Results 
   
37 
 
the frequency distribution plots show a clear shift in the cell distribution that is similar 
to the untreated cell population. On one hand, these data suggest that Wnt11 regulates 
the CT isoform generation via AKAP anchored PKA signaling. On the other hand, the 







3.4 AKAP2 anchored PKA signaling regulates the CT formation 
downstream of Wnt11 
 
3.4.1 Identification of AKAP candidates which might have a role in the CT 
formation 
The fact that some AKAP proteins function in the LTCC regulation has been already 
demonstrated, however, these data are not completely consistent. The underlying 
reason could be that several studies assume AKAP function in the LTCC regulation 
based on the observations using different cell lines like oocytes, skeletal muscle cells, 
HEK293 cells, tsA-201 cells, hippocampal neurons or cardiomyocytes from different 
origins. Obviously, AKAPs that may target PKA to the LTCC in neurons, are not 
Figure 12: Wnt11 signaling regulates CT formation via AKAP anchored PKA 
signaling. (A) Maximum intensity projection of confocal images of H9c2 cells 
immunostained with anti-pCt (Abcam) (gray/magenta) and anti-Nuc (green). Cells were 
treated with 10 µM PKI or with 100 µM L314E for 1 hour in the presence of WNT11 siRNA. 
(N ≥ 3 experiments; n ≥ 83). (B-C) Quantification of mean intensity of pCt antibody in 
nucleoli of H9c2 cells. Data of column graphs expressed as mean ± SD of N ≥ 3 experiments 
and n ≥ 83. Frequency distribution plots demonstrate the percentage of the cell population 
with the corresponding mean intensity. (*P=0.0363; **P=0.0016; Welch’s t test). The scale 







necessarily the same that may target PKA to the LTCC in cardiomyocytes. To identify 
AKAPs that are important in the CT isoform regulation in cardiomyocytes, I performed 
a midi-screen in collaboration with Mai Phan. In human 17 AKAP genes are annotated 
and I focused on those ones, which show heart specific expression; 10 AKAPs showed 
heart specific expression based on Human Protein Atlas expression data. Next, using 
Gene Ontology 6 AKAPs were selected, which are membrane localized and have PKA 
and ion-channel binding domain. The last criterion was that the selected AKAP must 
have zebrafish orthologue. Based on these requirements the following AKAPs were 
selected: AKAP2, AKAP6, AKAP10, AKAP11, AKAP12 and AKAP13. TBLAST of these 
genes against the zebrafish genome using Ensembl Genome Browser revealed that 
the AKAP2 zebrafish orthologue is called palm2-201/202. The zebrafish palm2-203 
transcripts from the same locus encodes Paralemmin 2, or Palm2 
(ENSDARG00000099005), a completely different protein from Akap2; the transcripts 
can also exist in a readthrough form as Palm2-Akap2. To avoid confusion, I am going 
to refer to zebrafish palm2-201/202 as akap2 for the rest of the study.  
The literature search revealed that most of the selected AKAPs are required for the 
maintenance of homeostasis in the heart, and that none of them were studied in the 
context of LTCC regulation (Diviani et al., 2011). I extended this list with AKAP5 and 
AKAP7, since many studies indicated their role in the LTCC regulation (Fuller et al., 
2014; Jones et al., 2012; Oliveria et al., 2007), although akap5 is not encoded in the 
zebrafish genome. 
The next aim was to determine the relative mRNA amount of the different akaps in 
cardiomyocytes (CM) in comparison with each other. To separate the CMs from the 
non-CMs, myl7:EGFP transgenic zebrafish line was utilized (Huang et al., 2003), 
where the myl7 promoter drives the heart specific expression of the EGFP. 
Fluorescence-activated cell sorting (FACS) of the EGFP positive cells followed by 
qPCR analysis revealed that in zebrafish embryos akap6 is not expressed in the heart, 
while akap11 is only expressed in CM cells. Furthermore, akap2, akap7, and akap12 
showed significantly higher expression levels in CMs compared to non-CMs (Figure 
13A). Comparison of the relative mRNA amount of the akaps in the CM revealed that 
akap12 is the most abundant with 41.8 %, and followed by akap2 with 27.1%, akap11 
with 15.8%, akap10 with 11.2%, akap7 with 3.0%, and akap13 with 1.1% (Figure 13B). 
These results are consistent with the expression data obtained by Tomo-seq (Burkhard 
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& Bakkers, 2018), where the highest mRNA expression levels in CMs considering 
akaps also belong to akap12 and akap2. In H9c2 cells, all eight AKAP candidates are 
expressed. Although, AKAPs showed different expression pattern in these cells, again 
AKAP12 (82.3%) and AKAP2 (6.6%) were the most abundant from the selected 
AKAPs. The rest of the AKAPs were expressed in small, but not negligible quantity, 
AKAP6 with 3.1%, AKAP13 with 2.4%, AKAP11 with 2.2%, AKAP5 with 1.8%, AKAP10 











3.4.2 Downregulation of the AKAPs induce the CT generation except AKAP2 
and AKAP5  
To explore AKAPs function in the CT isoform generation, I first showed in collaboration 
with Mai Phan that downregulation of the AKAPs with siRNA is efficient (Figure S3A-
H). Interestingly, single knockdown of the AKAPs in most cases considerably 
increased the CT formation as this phenomenon appeared in AKAP6, AKAP7, 
AKAP10, AKAP11, AKAP12, and AKAP13 siRNA transfected cells (Figure 14C-H). 
These data indicate on one hand that these AKAPs are not essential in the CT 
Figure 13: Identifying AKAP candidates which might have a role in the CT formation. 
(A) Relative mRNA expression of selected akap genes was measured in CM and non-CM 
after FACS of cell lysate from myl7:EGFP transgenic line via quantitative RT-PCR and 
normalized to the relative mRNA expression of eef1a1l1. Data represent the fold change 
log2 (2^-∆∆Ct) of the indicated genes in CM compared to non-CM. (Mean ± SD of N = 3 
experiments; **P(akap2)=0.0039; *P(akap7)=0.0391; ns P(akap10)=0.0781;                           
ns P(akap12)=0.0079; ns P(akap13)=0.0625;  Wilcoxon test). (B-C) Pie chart of the relative 
mRNA expression of the selected AKAPs. (B) Relative mRNA expression of akaps was 
measured in CM after FACS of myl7:EGFP transgenic line via quantitative RT-PCR and 
normalized to the relative mRNA expression of myl7. (C) Relative mRNA expression of 
AKAPs was measured in untreated H9c2 cell via quantitative RT-PCR and normalized to 
GAPDH. Data represent the fold change (2^-∆∆Ct) of the interested genes. (N= 3 






formation, and on the other hand it showed that the disruption of the balance between 
the different AKAPs can trigger the AKAP anchored PKA signaling, revealed as the 
enhanced cleavage of the CT. Comparison of the pCt intensities in the nucleoli in 
untreated cells and AKAP siRNA transfected cells indicated that the pCt intensity 
increased in the absence of AKAP11 by 65%, in the absence of AKAP12 by 63%, in 
the absence of AKAP6 by 51%, in the absence of AKAP7 by 40%, in the absence of 
AKAP10 by 40%, and in the absence of AKAP13 by 25%. However, neither loss of 
AKAP2 nor AKAP5 enhanced significantly the pCt intensity in the nucleoli compared 







Figure 14: Downregulation of AKAPs induce the CT generation, except AKAP2 and 
AKAP5. (A-H) Quantification of mean intensity of pCt antibody in nucleoli of H9c2 cells 
transfected with selected AKAP siRNA. Data of column graphs expressed as mean ± SD of 
N = 3 experiments and n is represented in the columns. Frequency distribution plots 
demonstrate the percentage of the cell population with the corresponding mean intensity. 
(ns P((-)AKAP2)=0.0925; ns P((-)AKAP5)=0.4926; ****P<0.0001; Welch’s t test). 
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3.4.3 Loss of AKAP2 rescues the loss of Wnt11 phenotype 
To identify which AKAPs are involved in the CT regulation downstream of the Wnt11 
pathway double knockdown of AKAP genes together with WNT11 were performed. 
Downregulation of WNT11 together with AKAP6, AKAP7, AKAP10, AKAP11, AKAP12 
or AKAP13 affected the pCt intensity in a similar way, as did the single knockdown of 
these AKAP genes. pCt intensity increased by 51% in WNT11/AKAP6, by 73% in 
WNT11/AKAP7, by 33% in WNT11/AKAP10, by 60% in WNT11/AKAP11, by 69% in 









Figure 15: Loss of AKAP2 rescues the loss of Wnt11 phenotype. (A-H) Quantification 
of mean intensity of pCt antibody in nucleoli of H9c2 cells, transfected with selected AKAP 
and WNT11 siRNA. Data of column graphs expressed as mean ± SD of N = 3 experiments 
and n is represented in the columns. Frequency distribution plots demonstrate the 
percentage of the cell population with the corresponding mean intensity. (*P((-)WNT11/(-






However, in case of double knockdown of AKAP5 together with WNT11 the loss of 
WNT11 phenotype was more prominent, since pCt intensity increased by 85%, which 
suggests that AKAP5 does not play a role in the CT formation (Figure 15B). 
Surprisingly, loss of AKAP2 partially rescued the loss of WNT11 effect on the CT 
formation, since pCt intensity only increased by 11%, which indicate that AKAP2 has 
a pivotal role in this process downstream of the Wnt11 pathway (Figure 15A). 
 
3.5 Regulation feedback loop between WNT11, AKAP2, and AKAP7 
As aforementioned, the cleaved CT isoform can translocate into the nucleus where it 
acts as a transcription factor. It has been shown by Gomez-Ospina and her colleagues 
that the overexpressed CT construct regulates the expression of gap junction proteins, 
regulators of G protein signaling, and tight junction proteins (Gomez-Ospina et al., 
2006). These proteins determine the voltage propagation abilities of an excitable 
tissue, therefore the cleavage of the CT must be tightly regulated. Considering the 
previous results that disturbing the balance between the different AKAPs had huge 
impact on the CT formation, I hypothesized the existence of compensatory 
mechanisms. To identify regulatory feedback loops between the Wnt11 signaling 
pathway and the following AKAPs: AKAP2, AKAP5 and AKAP7, qPCR analysis was 
performed. Downregulation of WNT11 had no effect on the AKAP5 expression levels, 
but on AKAP2 and AKAP7 (Figure 16A). While loss of WNT11 increased the 
expression of AKAP2, it had an opposite effect on AKAP7 (Figure 16A). Measuring 
WNT11 expression in AKAP5 siRNA transfected cells revealed that there is no 
feedback loop between WNT11 and AKAP5. However, downregulation of AKAP2 
reduced WNT11 amount. Although WNT11 mRNA expression was not significantly 
different in the absence of AKAP7 compared to its amount measured in scramble 
siRNA transfected cells, probably because of the huge standard deviation (SD), we 
can conclude that AKAP7 may have an impact on its expression (Figure 16B). These 
data strengthened the hypothesis that there is feedback loop system between WNT11 
and AKAP2 as well as between WNT11 and AKAP7. 
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3.6 AKAP2 forms complex with PKA and LTCC 
 
3.6.1 AKAP2 binds the PKA Regulatory subunit I and II 
AKAP2 has been shown to binds the PKA regulatory subunit II (Dong, Feldmesser, 
Casadevall, & Rubin, 1998; Gold et al., 2012), however other study suggested that 
AKAP2 similarly to AKAP10 can bind the regulatory subunit I and II as well (Aye et al., 
2009). To study AKA2 binding specificity to the different PKA regulatory subunits, 
protein spot array was performed in collaboration with Maike Schulz. Each peptide spot 
includes 25 amino acids residues of a subunit type (Figure 17A) and two neighbor 
spots share the same 20 amino acids (see Table S4). For FLAG-IP H9c2 cell lysates 
were used, which beforehand were either transfected with empty FLAG/HA or with 
FLAG/HA-AKAP2 plasmids. Incubation of the membrane with the control protein 
lysates and detection with anti-FLAG antibody revealed the unspecific binding sites, 
labeled with red (Figure 17B). The incubation of the membrane with the lysate including 
the overexpressed AKAP2 (Figure 17C) resulted in three additional red spots (A3, A5 
and B6), which indicate that AKAP2 can bind the PKA-RIa and –RIIa subunits. This 
finding suggests that AKAP2 indeed has dual specificity. 
Figure 16: Regulatory feedback loop between WNT11, AKAP2, and AKAP7. (A) 
Relative mRNA expression of the interested AKAP was measured in Scramble and WNT11 
siRNA transfected H9c2 cell via quantitative RT-PCR and normalized to the relative mRNA 
expression of GAPDH in Scramble siRNA transfected cells. Data represent the fold change 
log2 (2^-∆∆Ct) of the indicated gene. (Mean ± SD; N = 3 experiments; *P(AKAP2)=0.0195; 
ns P (AKAP5)=0.8203; **P(AKAP7)=0.0039; Wilcoxon test). (B) Relative mRNA expression 
of WNT11 was measured in Scramble and in indicated AKAP siRNA transfected H9c2 cell 
via quantitative RT-PCR and normalized to the relative mRNA expression of GAPDH in 
Scramble siRNA transfected cells. Data represent the fold change log2 (2^-∆∆Ct) of  wnt11. 
(Mean ± SD; N = 3 experiments; **P((-)AKAP2)=0.0039; ns P((-)AKAP5)=0.6406;                                                








3.6.2 CT construct undergoes cleavage 
The immunostaining experiments (Figure 15) suggested that AKAP2 is important for 
the CT isoform generation however, nothing is known about its function in the LTCC 
regulation. Hence the next goal of this study was to show the interaction between this 
novel AKAP and the α1C subunit. I designed a CT construct, which contains the rat 
α1C subunit (ENSRNOT00000052017.6) from amino acid (aa) 1317 to 2006, tagged 
with FLAG on the N-terminal part, and with mVenus on the C-terminal part as it is 
illustrated in Figure 18A. Immunostaining of the transfected cells with this construct 
showed that the CT is transported from the Golgi to the membrane (Figure 18B), 
suggesting its functionality. Next, I performed in collaboration with Maike Schulz 
immunoprecipitation (IP) experiments with FLAG and GFP antibodies (Figure 18C-D). 
During the detection of the FLAG-IP with FLAG antibody, a fragment around 130 kDa 
was detected, which corresponds to the full-length construct. A shorter fragment 
appeared around 80 kDa, which corresponds to the CT construct without mVenus, 
while an additional fragment was detected around 30 kDa, which corresponds to the 
pCT. During the detection of the FLAG-IP with GFP antibody only one band appeared 
around 130 kDa. GFP-IP of the construct and detection with FLAG antibody resulted 
in a band around 130 kDa. However, detection of the GFP-IP with GFP antibody 
resulted in two additional bands. One appeared around 90 kDa, which corresponds to 
dCT-mVenus. The other one was around 30 kDa, which is probably the cleaved 
Figure 17: AKAP2 forms 
complex with PKA-RIa and –RIIa. 
(A) Schematic representation of 
series of immobilized 25-mer 
peptides (see Table S4), moving 
along the different PKA regulatory 
subunits were synthesized by spot 
array. (B) EV-FLAG/HA or (C) 
FLAG/HA-AKAP2 transfected 
H9c2 lysates, followed by FLAG-IP 
were added to the membranes. 
The membranes were developed 
with anti-FLAG antibody (Sigma 
1:1000). Binding determinants are 
highlighted in red. 
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mVenus alone. Although the full-length construct is only 105 kDa, these data indicate 
that the band at 130 kDa is identical with the full-length construct. The existence of a 
30 kDa fragment during the FLAG-IP FLAG antibody detection and a 90 kDa fragment 
during GFP-IP GFP antibody detection suggest that the CT construct is proteolytically 
processed possibly at the calpain cleavage site (aa 1631-1637) (Hulme et al., 2005). 
In addition, 7 extra bands were detected during the FLAG-IP FLAG antibody detection 
(Figure 18C), which either indicates the existence of other cleavage sites or other 









3.6.3 Binding between CT construct and AKAP2 
To show that AKAP2 is binding to the CT construct, first the anti-AKAP2 antibody was 
verified. Using lysate from untreated H9c2 cells at least 5 bands appeared between 
Figure 18: Overexpressed CT construct undergoes cleavage. (A) Schematic 
representation of the FLAG and mVenus tagged CT construct, which contains the rat α1C 
subunit (ENSRNOT00000052017.6) from amino acid (aa) 1317 to 1981. Scissors indicates 
the published calpain cleavage site (aa 1631-1638). EC- extracellular, IC- intracellular (B) 
Maximum intensity projection of confocal image of H9c2 cells, which were transiently 
transfected with the construct. The scale bar represents 20 µm. (C) FLAG or (D) GFP 
detection by WB of the aforementioned construct from lysate of H9c2 cells either 
transfected with the construct or with empty vector GFP (EV-GFP) control before and after 






100 and 180 kDa, which showed significantly reduced signal in AKAP2 but not in 
WNT11 siRNA transfected cells (Figure 19A). In rat only two isoforms of AKAP2 
(F1LPQ9 and A0A096MJ48) are annotated so far. Using Promega BioMath calculator 
the predicted molecular weight of these isoforms were 95.7 KDa and 13.9 KDa. These 
data suggest that the detected bands could be different isoforms and/or dimerized 










Next, Co-IP experiments were performed in collaboration with Maike Schulz. FLAG-IP 
of the construct and detection with AKAP2 antibody resulted in a band around 130 kDa 
(Figure 19B), which could be one of the AKAP2 isoform. Reciprocal co-IP by IP the 
Figure 19: Binding between exogenous CT construct and AKAP2. (A) Western blot 
(WB) analysis of AKAP2 in lysate of untreated control (U) and WNT11 (W11) and AKAP2 
(A2) siRNA transfected H9c2 cells detected with anti-AKAP2 antibody. Below, cell lysate 
lanes were run on the same gel, but the membrane was cut as it is indicated by the gap 
and developed with β-actin. On the right, column graph represents the AKAP2 protein 
amount, which was normalized to β-actin amount. (Mean ± SD; N = 4;                                           
ns P((-)WNT11)=0.5206; *** P((-)AKAP2)=0,0002); One-way ANOVA, Dunnett‘s multiple 
comparison test.) (B) CT construct or EV-GFP were transiently expressed in H9c2 cells and 
the cell extract was IPed with FLAG, and co-IPed proteins were probed on WB with AKAP2. 
(N ≥ 3 experiments). (C) Endogenous AKAP2 was IPed from CT construct or EV-GFP 
control transfected H9c2 cell extracts with AKAP2 antibody. The IP probed on WBs with 
antibodies to the indicated proteins. (N = 3 experiments). 
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endogenous AKAP2 and detection of the construct with FLAG antibody resulted in a 
band around 130 KDa, which corresponds to the full-length construct (Figure 19C). 
These data indicate that AKAP2 binds to the CT. 
 
3.6.4 Binding between endogenous LTCC and AKAP2 
The following aim was to study the interaction between the endogenous AKAP2 and 
LTCC proteins. Therefore, an anti-pCt antibody was generated, which targets the pCT 
at aa 1570-1589. Beforehand, I verified the specificity of this antibody, which 
theoretically recognizes the full-length and also the cleaved α1C subunit. On WB only 
one band appeared around 250 kDa, which showed decreased signal in CACNA1C 
siRNA transfected cells compared to untreated cells (Figure 20A). This result suggests 
that the pCt antibody only recognizes the full-length isoform. Next, in collaboration with 
Maike Schulz, endogenous AKAP2-IP was performed using lysates of Scramble or 
AKAP2 siRNA transfected cells. With AKAP2 antibody, 3 AKAP2 isoforms were 
detected in the Scramble siRNA transfected cell lysate. Re-staining the same 
membrane with the anti-pCt resulted in an additional band around 250 kDa (labelled 
with asterisk) in the Scramble siRNA transfected cells, but not in AKAP2 siRNA 
transfected cells (Figure 20B). This band corresponds to the full-length subunit and 
suggests the interaction between AKAP2 and α1C subunit. Taken together, these data 







Figure 20: Binding between endogenous LTCC and AKAP2. (A) WB analysis of LTCC 
in lysate of untreated control and CACNA1C siRNA transfected H9c2 cells by using anti-
pCt antibody (custom-made). Below, cell lysate lanes were run on the same gel, but the 
membrane was cut as it is indicated by the gap and developed with β-actin. (N = ≥ 3 
experiments). (B) Endogenous AKAP2 was IPed from Scramble or AKAP2 siRNA 
transfected H9c2 cell extracts with AKAP2 antibody. The IP probed on WB with antibodies 





3.7 Akap2 regulates heart formation  
 
3.7.1 Characteristics of loss of Akap2 phenotype 
Little is known about AKAP2 function apart from its role in calcitonin-mediated cancer 
cell invasion (Thakkar et al., 2016) or in ocular transparency (Gold et al., 2012). We 
previously showed by qPCR that akap2 (palm2-201/202) is highly expressed in 
zebrafish cardiomyocytes (Figure 13A). Furthermore, it has been shown that PKA-
AKAP2 interaction is highly upregulated in human patients with dilated cardiomyopathy 
(DCM) (Aye et al., 2012). To further our understanding of Akap2 function during cardiac 
development loss of function experiments were performed using morpholino approach. 
The akap2 is composed of 5 exons, from which the exon 2 consists of the PKA binding 
domain (LZ motif, green in Figure 21A). Keeping this in mind, the akap2 morpholino 
(akap2e2i2MO) was designed in a way to cause the exclusion of exon 2 (akap2∆ex2) 
(Figure 21A). The akap2 morpholino-injected wild-type, 54 hours after postfertilization 
(hpf) embryos were shorter, developed heart edema and had small head compared to 
uninjected control embryos (Figure 21B). To confirm the exclusion of the exon 2, after 
RNA extraction from wild-type and akap2 morphant embryos cDNA was synthetized. 
Next, the template cDNAs were amplified using primers, which target the beginning 
and the end of the akap2. In wild-type embryos a PCR product was detected between 
2000 and 2500 bp, which is corresponds to the full-length akap2 (2434 bp). In akap2 
morphant embryos a fragment appeared around 320 bp, which corresponds to 
akap2∆ex2 (Figure 21C). The phenotypic analysis of the injected embryos focusing on 
the heart revealed that a little bit less than half of the akap2 morphants had unlooped 
heart compared to wild-type embryos, which I defined as abnormal looping (Figure 
21D). Furthermore, in akap2 morpholino-injected embryos the inverted heart occurred 
more frequently compared to wild-type embryos. 
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To ensure that the aforementioned phenotypic characteristics of loss of the akap2 are 
not off-target effects of the morpholino, I cloned the akap2 mRNA. To estimate the 
concentration of the mRNA, which has no effect on the development, but rescues the 
morpholino caused phenotype, titration curve of the mRNA was executed (Figure 
SF4A-C).  Although, injection of 50 pg/ul akap2 mRNA alone had no effect on the 
development, injection of the mRNA with the morpholino resulted in abnormal looping 
in 32.8%, and inverted heart in 6.3% of the embryos (Figure SF4A). 15.4% of the 
embryos injected with 100 pg/ul akap2 mRNA had severe phenotype (Figure SF4C), 
and injection of the mRNA in higher concentrations caused massive death in the 
population (data not shown). However, 75 pg/ul akap2 mRNA together with the 
morpholino efficiently rescued the loss of akap2 phenotype, without causing any effect 
alone (Figure 22A and 22B).  
Figure 21: Loss of akap2 phenotype. (A) Schematic representation of the zebrafish wild-
type (WT) akap2 and morpholino induced exclusion of exon 2 (akap2∆ex2). The exons are 
not to scale. LZ-Leucine zipper motif (B) In vivo bright field image, lateral view of WT and 
akap2 morpholino (akap2e2i2MO) injected embryos at 54 hpf. (arrowhead - heart edema; 
asterisk-small head) (C) RT-PCR of akap2 cDNA from WT and akap2 morpholino-injected 
embryos at 54hpf. The size of the akap2 fragment is 2434 bp, while in akap2 morphants it 
is only 300 bp due to exclusion of the exon 2 (2134 bp). (D) Quantification of the loss of 









3.7.2 Akap2 is required for normal heart development 
In developing zebrafish embryo cardiac looping occurs from 30 to 48 hpf, when the 
linear heart tube morphs into two chambers, and the ventricle and atrium become 
morphologically distinguishable. To visualize and measure the looping defect in akap2-
deficient heart, myl7:EGFP transgenic line was injected with akap2 morpholino, akap2 
mRNA or in combination (Figure 23A). The heart angle was defined as the angle, which 
is enclosed by the midsagittal line and the atrioventricular canal, and indicates the 
relative position of the atrium to the ventricle (Figure 23B). In 54 hpf uninjected control 
embryos the averaged mean angle was 18.9° ± 7.4°, which implicates the properly 
looped heart, as the atrium is almost juxtaposed to the ventricle. Injection of akap2 
morpholino enhanced the angle. The akap2 morphants had 62.4° ± 12.8° angle, in 
which case the atrium was diagonally below the ventricle. Injection of akap2 mRNA 
alone had no effect on heart looping (17.3° ± 6.7°), however co-injection with akap2 
morpholino together successfully rescued the lopping defect (22.7° ± 7.9°) (Figure 
23C). Taken together, loss of akap2 results in heart edema, heart looping defect, 
smaller head and reduced body length, which can be rescued with akap2 mRNA. This 
indicates that the observed phenotypical characteristics are specific for loss of akap2 
Figure 22: Rescue of akap2 phenotype. (A) In vivo bright field image, lateral view of WT 
zebrafish embryo and WT embryo injected with akap2 morpholino (akap2e2i2MO), akap2 
mRNA (75 pg/µl akap2), and with mRNA and morpholino together. (arrowhead- heart 
edema; asterisk-small head) (B) Quantification of the loss of akap2 phenotype based on 
heart looping abnormalities. (N ≥ 3 experiments; n ≥ 300). 
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and not off-target effects of the morpholino. Hence, these data suggest that Akap2 








3.8 In developing zebrafish heart the LTCC abundance and 
localization is regulated by Wnt11 and Akap2-PKA signaling  
 
3.8.1 Wnt11 regulates the expression of the cacna1c gene 
The zebrafish α1C subunit of the LTCC is encoded by the cacna1c gene 
(ENSDARG00000008398), which contains 48 exons. To study whether Wnt11 
signaling pathway regulates the calcium transient amplitude via LTCC in zebrafish, first 
the expression level of the cacna1c was examined using wnt11tx226 mutant embryos 
(Heisenberg et al., 2000) at 54 hpf. Considering the following facts: a) in mouse the 
dCT isoform can be transcribed independently from the full-length CACNA1C (Gomez-
Figure 23: Akap2 is required for normal heart development. (A) Bright field image 
overlayed with fluorescent image, frontal view of uninjected control, akap2 mRNA (75 pg/µl 
akap2) injected, akap2 morpholino (akap2e2i2MO) injected or mRNA and morpholino double 
injected myl7:EGFP transgenic zebrafish embryo at 54 hpf. (B) Schematic representation 
of the measured heart angle, which is defined by the midsagittal line and atrioventricular 
canal. (C) Quantification of the heart angle. Data expressed as mean ± SD of at least 5 
embryos in each condition, n is represented on the columns. (**P(akap2e2i2MO)=0.0043;     
ns P(75 pg/µl akap2)=0.9444; ns P(75 pg/µl akap2/akap2e2i2MO)=0.5317; Mann-Whitney 






Ospina et al., 2013), b) in H9c2 cells I detected reduction in expression of CACNA1C 
exon 45 (dCT isoform) in the absence of WNT11, three TaqMan probes were used, 
which target the cacna1c exon 18, 40 and 45. These exons encode part of the pore-
forming domain (exon 18), of the pCT (exon 40) and dCT (exon45) (Figure 24A). 
Surprisingly, in wnt11 mutant embryos the expression levels of the cacna1c gene was 
decreased compared to wild-type embryos, independently from the TaqMan probes 
(Figure 24B). These data indicate that Wnt11 signaling may regulate the cacna1c 
expression. However, it has to be mentioned that RNA extracts were prepared from 
the whole embryos, therefore this effect of Wnt11 on the channel expression is general 








3.8.2 LTCC abundance and localization in zebrafish embryonic ventricle 
My next aim was to determine whether Wnt11 and Akap2-PKA signaling pathway 
regulate the localization and abundance of the α1C subunit in the zebrafish embryonic 
heart. To address this question, first the II-III-loop antibody specificity was verified in 
zebrafish; this part of the α1C subunit is highly conserved between the species (Figure 
S5). In ventricle from 54 hpf wild-type embryo the α1C subunit showed membrane 
localization, where the channel clusters appeared in continuous or dashed stripes 
along the cells’ circumference (Figure 25A). Midsagittal section through the ventricle 
Figure 24: Wnt11 signaling alters cacna1c expression. (A) Schematic representation 
of the zebrafish LTCC complex with the highlighted sites for the TaqMan probes on the 
α1C subunit (ENSDARG00000008398). EC- extracellular, IC- intracellular (B) Relative 
mRNA expression of cacna1c gene was measured in WT and wnt11 mutant                           
((-/-)wnt11tx226) embryos at 54 hpf via quantitative RT-PCR and normalized to the relative 
mRNA expression of eef1a1l1. Data represent the fold change log2 (2^-∆∆Ct) of the 
interested genes. (Mean ± SD of N = 3 experiments; **P(cacna1c exon 18)=0.0039;             
**P(cacna1c exon 40)=0.0078; **P(cacna1c exon 45)=0.0039; Wilcoxon test). 
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revealed that the channel shows lateral localization within the polarized cardiac 
epithelial cells (Figure 25A’). The qPCR data indicated that loss of wnt11 might reduce 
the cacna1c expression in CMs, and thus possibly its protein abundance. Although, in 
contrast to the expected results, injection of the embryos with wnt11 morpholino 
(wnt11ATGMO) had no effect on the α1C subunit abundance, it disturbed the 
localization of the channel. In wnt11 morphant ventricle the well-defined pattern of the 
channel, which followed the shape of the cells was perturbed (Figure 25B). Injection of 
akap2 morpholino resulted in the continuous localization of the α1C subunit along the 
lateral cell membranes of the epithelial myocardial cells. In comparison to the wild-type 
embryos, in the absence of akap2 the channel clusters formed by dashed stripes along 
cells’ circumference were never observed (Figure 25C). In addition, in akap2-deficient 
heart the extracellular matrix between the endocardium and myocardium showed 
increase, the endocardium became compact, and the myocardial monolayer was 
replaced by double layer (Figure 25C’) indicating the role of Akap2 in tissue 






Figure 25: Localization and abundance of the α1C subunit. Maximum intensity 
projection of 7 µm confocal section (A,B,C) or 2,8 µm confocal section (A’,B’,C’)  of (A) WT, 
(B) wnt11ATGMO and (C) akap2e2i2MO zebrafish hearts at 54hpf. Hearts were 
immunostained with anti-II-III-loop antibody (Millipore) in dilution of 1:50 (gray). DAPI (blue) 





Detailed analysis of ventricles from wild-type embryos revealed that in the myocardium 
based on the α1C subunit distribution we can distinguish between three transversal 
layers. The LTCC appeared the most abundant in the apical section, where the clusters 
of the channels were equally scattered along the membranes (white channel in merged 
images show channel co-localization with ZN8 antibody) (Figure 26A-C). The channels 
become more clustered in patches along the membranes represented by dashed 
stripes along the cells’ circumference in the middle sections. Here, the channel formed 
elongated clusters perpendicular to the membrane (Figure 26B). In the basal sections, 
the channel is only visible sparsely, in dispersed small clusters at the cell boundaries. 
The α1C subunit abundance decreased and compared to the other two section I 






Considering the distribution of the α1C subunit in wild-type myocardium, I analyzed the 
distribution of the α1C subunit in ventricles dissected from wnt11 or akap2 morphant 
embryos (Figure 27). In the absence of wnt11, the channel localized in a very similar 
fashion in the apical as well as middle sections as seen in wild-type embryos. However, 
Figure 26: α1C subunit distribution within the WT myocardium. Maximum intensity 
projection of 2.1 µm transversal (A) apical, (B) middle or (C) basal section of WT zebrafish 
epithelial myocardium at 54hpf. Hearts were immunostained with anti-II-III-loop antibody 
(Millipore) in dilution of 1:50 (gray/green), anti-ZN8 antibody (Hybridoma Bank) in dilution 
of 1:50 (magenta). DAPI (blue) stains nuclei. (N ≥ 3 experiments). The scale bar represents 
10 µm. 
 
           Results 
   
55 
 
in the basal sections its localization was similar to apical and middle sections, and thus 
was not downregulated (Figure 27B). Analyzing the maximum projections of the 
myocardium of several wnt11-deficient hearts (Figure S6) indicated that Wnt11 
signaling regulates the LTCC localization in developing zebrafish heart. In the absence 
of akap2, the channel distribution was quite similar in all three sections (Figure 27C). 
In the apical sections, the channels were clustered in continuous lines, which defined 
the cell borders. This pattern of the channels was also typical in the middle sections, 
where it supposed to form dashed stripes. Although in the basal sections the channel 
abundance was reduced its pattern was similar as in the apical sections. Comparison 
of the different hearts isolated from akap2 morphant embryos showed similar pattern 





Figure 27: α1C subunit distribution in the myocardium. Maximum intensity projection of 
2.1 µm transversal (A,B,C) apical, (A’,B’,C’) middle or (A’’,B’’,C’’) basal section of (A) WT, 
(B) wnt11 (wnt11ATGMO) or (C) akap2 (akap2e2i2MO) morphant myocardium at 54hpf. Hearts 
were immunostained with anti-II-III-loop antibody (Millipore) in dilution of 1:50 (gray). DAPI 






3.9 Loss of akap2 rescues the electrical gradient formation in wnt11-
deficient embryonic zebrafish heart 
 
3.9.1 akap2 interacts with wnt11 genetically  
To determine whether Wnt11 and Akap2 cooperate during development, phenotypic 
analysis of double injected embryos with akap2 and wnt11 morpholino was performed 
(Figure 28A). The wnt11 morphants developed fused eyes, forebrain abnormalities, 
shorter body length and cardiac edema. The group with cyclopic eye also had cardiac 
edema and abnormal looping. 40% of the embryos injected with wnt11 morpholino 
showed cyclopic eye and additional 10% of the population had abnormal looping. In 
wnt11; akap2 double morphants overall 59.5% of the embryos were effected. The 
severe phenotype increased by 5.8% compared to the wild-type group. However, 
16.5% less of these embryos developed cyclopic eye, and by 16.3% more had 








Figure 28: Loss of akap2 and wnt11 phenotype. (A) In vivo bright field image, lateral 
view of WT zebrafish embryo and WT embryo injected with akap2 morpholino 
(akap2e2i2MO), with wnt11 morpholino (wnt11ATGMO), and with both at 54 hpf. (arrowhead- 
heart edema; asterisk-cyclopic eyes; arrow-smaller head) (F) Quantification of the 
phenotypes based on heart looping abnormalities and cyclopia. (N ≥ 3 experiments; n ≥ 
300). (C) RT-PCR of akap2 cDNA from WT and double morpholino injected embryos at 54 
hpf. The size of the akap2 fragment is 2434 bp, while in akap2; wnt11 morphants it is only 
300 bp due to exclusion of the exon 2 (2134 bp). 
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The embryos, which developed fused eyes were used for further studies as they are 
representative of the wnt11 knockdown phenotype. One of these embryos is 
represented on the Figure 28A. Beside the cyclopia these embryos also developed 
heart edema, however body length and brain abnormalities seemed to be rescued by 
loss of akap2. To prove that these embryos were indeed missing the akap2, RNA 
isolation was performed followed by cDNA synthesis. RT-PCR analysis of cDNA 
amplified with akap2 primer set from wild-type and double morphant embryos 
confirmed the exon 2 exclusion in akap2 in double morphants (Figure 28C). These 
data implicate that loss of akap2 might suppress particular aspects of the wnt11 
phenotype. 
To visualize the looping defect, myl7:EGFP transgenic line was injected with wnt11 
morpholino alone and in combination with akap2 morpholino (Figure 29A). During 
quantification enhanced heart angle was measured (32.5° ± 13.0°) in wnt11 morphant 








Figure 29: Loss of akap2 is dominant over loss of wnt11 heart phenotype. (A) Bright 
field image overlayed with fluorescent image, frontal view of uninjected control, akap2 
morpholino (akap2e2i2MO) injected, wnt11 morpholino (wnt11ATGMO) injected, and double 
injected myl7:EGFP transgenic zebrafish embryo at 54 hpf. (B) Quantification of the heart 
angle. Data expressed the mean ± SD of at least 5 embryos in each condition, n is 
represented in the columns. (**P(akap2e2i2MO)=0.0043; *P(wnt11ATGMO)=0.0420;                 







However, in the double morphants with cyclopic eye this angle was even larger, 47.9° 
± 3.1°, which is similar to the heart angle in akap2 morphant (62.4° ± 12.8°) (Figure 
29B). This data suggest that loss of akap2 concerning the heart phenotype is dominant 
over loss of wnt11, indicating that akap2 might be downstream of wnt11. 
 
3.9.2 Loss of akap2 rescues the electrical gradient formation in wnt11-deficient 
embryonic heart 
Cardiac pacemaker induces propagation of the action potentials from the atrium to the 
ventricle, where in normal condition at 54 hpf the cardiomyocytes of the outer curvature 
(OC) of the ventricle conduct action potentials three times faster than the inner 
curvature (IC) cardiomyocytes. This intercellular electrical coupling gradient is 
essential for the normal function of the heart and prerequisite for the generation of the 
sequential contraction. It has been shown that Wnt11 pathway is indispensable for the 
establishment and maintenance of the electrical gradient in developing zebrafish heart 
(Panáková et al., 2010).  
To examine what is the physiological relevance of Akap2 in action potential 
propagation, optical mapping of zebrafish hearts at 54 hpf was performed. The 
conduction velocity was measured in the OC and IC regions and plotted as a ratio of 
the OC/IC. In uninjected control wild-type embryos this number was on average close 
to three (3.21 ± 0.54; n=32; data not shown) as it was previously reported. In akap2 
morphants, this ratio was 2.20 ± 0.61 (Figure 30B) meaning that the gradient formation 
was disturbed in these embryos. 75 pg/µl akap2 mRNA injection had no significant 
effect on the action potential propagation compared to its wild-type control, since the 
ratio in these ventricles was 3.07 ± 0.79 (Figure 30C). In akap2 mRNA and morpholino 
injected embryos the ratio was 3.06 ± 1.18 similar to the wild-type (Figure 30D). This 
means that mRNA injection successfully rescued the akap2 morpholino phenotype, 
hence the loss of akap2 effect on the electrical gradient formation is most likely a 
specific effect of the morpholino.  
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In addition, I confirmed that in wnt11-deficient heart either in wnt11 mutant or 
morphant, the conduction velocity gradient formation was abolished, which is in line 
with published data (Panáková et al., 2010). The ratio between OC/IC in wnt11 mutant 
was 1.65 ± 0.70 (Figure 31B), and in morphant was 1.47 ± 0.32 (Figure 31C). 
Figure 30: Akap2 regulates the electrical gradient formation. (A) Isochronal map of 54 
hpf zebrafish heart from wild-type, akap2 morphant, akap2 mRNA injected, and akap2 
mRNA and morpholino injected embryos. Lines represent the positions of the action 
potential wave front at 5-ms intervals. Red dots indicate the start site of the excitation and 
blue dots represent the end. (IC-inner curvature, OC-outer curvature) (B-D) Quantification 
of the action potential propagation at 54 hpf (B) in akap2 morpholino (akap2e2i2MO), (C) 
akap2 mRNA (75 pg/µl akap2), and (D) in akap2 mRNA and morpholino (75 pg/µl 
akap2/akap2e2i2MO) injected embryos. Data are expressed as the ratio of the OC/IC 
conduction velocity and are plotted as mean ± SD of N=3 experiments and n is represented 
on the columns. (*P (akap2e2i2MO)=0.0118; ns P(75 pg/µl akap2)=0.9999;                                  












Surprisingly, measuring the conduction velocity in the double wnt11; akap2 morphants 
revealed that in these embryos the electrical gradient formation was completely 
rescued, since the ratio between OC/IC was at 3.22 ± 0.60 (Figure 32). This data 
indicates that regarding the LTCC regulation, Akap2 acts downstream of Wnt11 
pathway, and that not just in H9c2 cells, but in zebrafish embryo as well. Thus, without 






Figure 31:  The action potential propagation in the hearts from wnt11 mutants and 
wnt11 morphants is similar. (A) Isochronal map of 54 hpf zebrafish heart from wild-type 
(uninjected), wnt11 mutant and wnt11 morphant embryos. (B-C) Quantification of the action 
potential propagation at 54 hpf (B) in wnt11 mutant ((-/-)wnt11tx226) and (C) in wnt11 
morphant (wnt11ATGMO) embryos. Data are expressed as the ratio of the OC/IC conduction 
velocity and are plotted as mean ± SD of N=3 experiments and n is represented on the 
columns. (*P((-/-)wnt11tx226)=0.0200; **P(wnt11ATGMO)=0.0012; Mann-Whitney test). 
 
 
Figure 32: Loss of akap2 rescues the electrical gradient formation in wnt11-deficient 
heart. (A) Isochronal map of 54 hpf zebrafish heart from wild-type and from double 
morphant (wnt11ATGMO/akap2e2i2MO) embryos. (B) Quantification of the action potential 
propagation at 54 hpf in the wild-type and in the double morphant embryos. Data are 
expressed as the ratio of the OC/IC conduction velocity and are plotted as mean ± SD of 
N=3 experiments and n is represented on the columns. (ns P(wnt11ATGMO/akap2e2i2MO) = 
0.2804; Mann-Whitney test). 
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In the current study, I describe signaling mechanisms regulating the electrical gradient 
formation via compartmentalized LTCC/AKAP2/PKA multivalent complex as a novel 
function of Wnt11 signaling in the heart. The main conclusions which could be drawn 
from this study are as follows: (1) Wnt11 regulates the nuclear localization of the CT of 
the α1C subunit via preventing it from proteolytic processing; (2) the CT isoform 
generation is dependent on the AKAP anchored PKA signaling downstream of the 
Wnt11 pathway; (3) a novel player, the AKAP2 binds to the LTCC and regulates the 
CT isoform generation; (4) in developing zebrafish ventricle Wnt11 and Akap2 define 
the distribution and cluster formation of the LTCC; (5) Wnt11 and Akap2 collaborate to 
maintain the electrical gradient formation. 
 
4.1 Wnt11/CT signaling 
Cardiomyocytes are coupled through intercalated discs, which not only provide 
mechanical connections between the cells, but also enable fast action potential 
propagation that is crucial for synchronous contraction. The intercalated disc is 
composed of desmosomes, adherens junctions and gap junctions (Rohr, 2004). The 
Cx43 is one of the most abundant gap junction protein in the heart and several studies 
suggest that its expression is under the control of Wnt signaling (van der Heyden et 
al., 1998). Western blot analysis of NRVMs revealed that WNT1, but not WNT4 
significantly increases the Cx43 abundance (Ai et al., 2000). Furthermore, 
overexpression of β-catenin enhanced the promoter activity of Cx43, which indicates 
that Wnt canonical signaling directly regulates the Cx43 expression (Ai et al., 2000). 
Furthermore, the downregulation of the Wnt non-canonical pathway has the same 
effect. This was demonstrated in wnt11-deficient zebrafish heart, where the Cx43 
abundance increased across the whole ventricle (Panáková et al., 2010). In 
accordance with this finding, western blot analysis using H9c2 cell lysates from 
untreated and WNT11 siRNA transfected cells confirmed that loss of WNT11 indeed 
results in elevated Cx43 abundance (Figure 5B and 5C). During cardiogenesis Wnt11 
pathway was shown to antagonize the Wnt canonical pathway, hence it decreases the 
nuclear level of the β-catenin (Cohen et al., 2012). This finding implicates that WNT11 





The current study showed that loss of WNT11 increased the basal levels of the CT of 
the α1C subunit thus resulted in more homogeneous cell population regarding the 
nuclear accumulation of the CT compared to untreated cells (Figure 9A and 9C). In 
addition, CT showed co-localization with nucleolin (Figure 9A and 9B), which indicates 
a potential role of CT in these structures. Nucleus gives place to ribosomal biogenesis 
and regulate cell cycle, stress response and telomerase activity (Pederson, 1998; 
Raška et al., 2006; Rubbi & Milner, 2003). However, the role of the CT in these 
processes needs to be elucidated. The observations that loss of WNT11 unaltered the 
expression level of the CACNA1C gene, except of the last exon, as well as the 
localization and abundance of pore-forming domain of the α1C subunit leads to the 
conclusion that the CT isoform was generated via proteolytic processing. The 
published cleavage site in rat α1C subunit (A0A0G2QC25) occurs between aa 
residues 1631-1645 (Hulme et al., 2005), and the anti-CACH2C antibody that was used 
for the immunostainings recognizes the pCT region between aa 1342-1568, i. e. 
upstream of this reported cleavage, implying the existence of an additional cleavage 
site upstream of aa 1568. This observation was strengthened by FLAG-IP of the 
overexpressed FLAG-CT-mVenus construct followed by the FLAG detection, which 
resulted in seven extra bands besides the expected cleaved fragments (Figure 17C). 
However, I could never verify the formation of the endogenous CT isoform due to 
negative reactivity of the antibodies on western blotting. Previously published data as 
well as my findings suggest the presence of several CT isoforms that can translocate 
into the nucleus, and potentially associate with other subcellular compartments thereby 
contributing to regulation of a number of physiological processes. 
The nuclear localization of the CT isoform in neurons and cardiomyocytes and its 
function as a transcription factor has been already demonstrated (Schroder et al., 
2009). Among others it can regulate the expression of several gap junction proteins 
like Connexin 31.1 (Gomez-Ospina et al., 2006). The behavior of the CT as a 
transcription factor offers an additional signaling pathway downstream of the Wnt11, 
which might also contribute to the regulation of Cx43 expression beside the regulation 
via β-catenin dependent signaling.  
The nuclear localization of the CT increased upon low extracellular calcium 
concentration and decreased upon high intracellular calcium concentration (Gomez-
Ospina et al., 2006). This suggest that the CT cleavage induces the channel 
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conductance, meanwhile in the nucleus it represses its own promoter activity 
(Schroder et al., 2009), thereby creating a negative feedback loop. The observations 
that in wnt11-deficient developing zebrafish heart the Ca2+ transient amplitude 
increased (Panáková et al., 2010), and that in H9c2 cells loss of WNT11 increased the 
CT nuclear localization are in accordance with the previous findings that CT formation 
induces the channel conductance. Furthermore, loss of FZD7, which is the putative 
receptor of WNT11 (Djiane et al., 2000) also resulted in increased nuclear localization 
of the CT (Figure 9B and 9D). In addition, stimulation of the β-AR pathway with ISO 
effected the CT isoform generation in a similar fashion as loss of WNT11/FZD7 did 
(Figure 10B), which suggests that stimulation of the Gs protein system may induce the 
CT isoform generation. In the light of these observations, WNT11/FZD7 presumably 
induces Gi protein coupled signaling, which antagonizes the Gs system, since the 
absence of this signaling resulted in the increment in the CT isoform generation as the 
stimulation of the Gs pathway did. These findings offer a mechanism, where 
downregulation of the WNT11 pathway can result in similar outcome considering the 
intracellular calcium concentration as its stimulation. Furthermore, the findings that 
FZD7 can couple with Gs, Gi and Gq proteins as well (von Maltzahn et al., 2012; Nichols 
et al., 2013) might suggest a possible switching mechanism between FZD7 and Gi or 
Gs proteins in a similar way as it is in the case of β2-AR (Daaka et al., 1997), which 
would offer an even more dynamic system to regulate the intracellular calcium levels. 
Taken together, these findings indicate the existence of a WNT11/CT signaling system 
that can establish the electrochemical properties of a cardiomyocytes via the regulation 
the calcium influx through the LTCC as well as via the regulation of the expression of 
proteins involved in the action potential propagation. 
 
4.2 AKAP2 forms multivalent complex with PKA, LTCC, and induces 
CT signaling  
Stimulation of the β-AR/Gs signaling pathway increases the cAMP levels and 
subsequently induces the PKA activation, and leads to phosphorylation of proteins 
involved in the E-C coupling. Consequently, this signaling results in the well-
characterized positive inotropic and lusitropic effects of the β-AR stimulation in 





glucagon-like peptide-1 receptor (GLP1R)/Gs signaling results in comparable cAMP 
levels as stimulation of the β-AR/Gs signaling does, it leads to a mildly negative 
inotropic and no lusitropic effect (Petroff et al., 2001). These findings indicate that 
increment in the global cAMP levels is irrelevant in regulating E-C coupling, and that 
the efficient phosphorylation of target proteins requires compartmentalized cAMP 
signaling. The compartmentalized cAMP signaling is accomplished via spatial 
localization in the close proximity of the key regulatory proteins in subcellular 
microdomains. LTCC was shown to co-assemble with β2-AR, Gs, AC, PKA and PP2A 
and form macromolecular signaling complexes (Davare, 2001). In addition, AKAPs 
ensure correct spatial and temporal positioning of PKA near to the phosphorylation 
target to facilitate the specificity of signaling events (Wong & Scott, 2004). Therefore, 
AKAPs play an essential scaffolding role in these macromolecular complexes.  
The dCT isoform generation and regulation of the α1C subunit through AKAP/PKA 
signaling and its role in the LTCC regulation has been well studied, however the 
formation of the CT isoform remained obscure. FSK treatment of the H9c2 cells 
showed that inducing the global PKA activity results in CT increment in the nucleus 
(Figure 10A and 10C), which strengthens the previous results that Gs protein signaling 
increases the CT isoform formation (Figure 10A and 10B). Furthermore, applying PKI 
in WNT11 siRNA transfected cells resembled the untreated cells, which indicated that 
local cAMP increment in the presence of inactivated PKA is unable to efficiently induce 
the CT cleavage (Figure 12A and 12B). Inhibition of the AKAP anchored PKA signaling 
masked the local PKA activity and resulted in only modest increment in the CT isoform 
generation compared to untreated cells (Figure 12A and 12C). These data indicate that 
the spatiotemporal targeting of PKA by AKAP is important in the CT isoform generation 
downstream of the WNT11 pathway. 
Over the last decades many AKAPs have been demonstrated in cardiomyocytes 
regulating calcium cycling, myofiber contractility, cardiac arrhythmias, hypertrophy, 
heart failure, and hypoxia (Diviani et al., 2016). AKAP1 is manly present in 
mitochondria, where it regulates the levels of reactive oxygen species and inhibits the 
activity of proapoptotic proteins (Perrino et al., 2010). AKAP5 is membrane associated 
and regulates the phosphorylation of LTCC, RyR2, PLN (Nichols et al., 2010), the 
trafficking of β-AR (Li et al., 2013) and regulates NFAT signaling (Murphy et al., 2014). 
AKAP6 is localized to the nuclear envelope (Pare et al., 2005) and regulates cardiac 
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hypertrophy as well NFAT signaling by recruiting PP2B (Li et al., 2010), RyR2 activity 
(Marx et al., 2000), myogenic differentiation (Vargas et al., 2012), and cardiac 
remodeling (Lee et al., 2015). It binds to PDE thereby induces local cAMP hydrolysis 
(Dodge-Kafka et al., 2005). AKAP7 is also a membrane-targeted protein as AKAP5. It 
directs PKA, PKC, and PP2A to the LTCC, hence it regulates the LTCC conductance 
(Hulme et al., 2003). AKAP9 regulates the action potential duration by targeting PKA 
to the potassium voltage-gated channel subfamily Q member 1 (Marx et al., 2002), and 
mediates cAMP hydrolysis via PDE binding (Terrenoire et al., 2009). AKAP10 
regulates transferrin receptor signaling (Eggers et al., 2009), and its mutation leads to 
impaired cardiac rhythm (Kammerer et al., 2003). AKAP12 forms multivalent complex 
with PKA, PKC, and PDE, and modulates Polo-like kinase 1 (Canton et al., 2012), β2-
AR desensitization as well as resensitization (Fan et al., 2001; Lin et al., 2000). 
AKAP13 was shown to form complex with Protein kinase D (PKD) (Carnegie et al., 
2004), PKA, and nucleates a G12-mediated Rho activation pathway via its Rho-
Guanine nucleotide exchange factor (GEF) activity (Diviani et al., 2001). It is 
cardioprotective and regulates hypertrophic signaling pathways (Carnegie et al., 2008; 
Edwards et al., 2012). In this study, I show that AKAP2 and AKAP11 are also 
expressed in embryonic zebrafish cardiomyocytes (Figure 13B) as well as in H9c2 cells 
(Figure 13C). However, their function in cardiomyocytes have not yet been 
demonstrated. AKAP2 is also membrane anchored, and forms complex with PKA and 
lens-specific aquaporin-0 (AQP0) (Gold et al., 2012). Furthermore, AKAP2/PKA 
interaction was highly upregulated in human patients diagnosed with DCM (Aye et al., 
2012), which implicates its role in cardiomyocytes. AKAP11 is able to form complex 
with PP1, PKA, and GSK3β in COS cells (derived from monkey kidney tissue), and 
decreases the activity of GSK3β via its phosphorylation by the kinases (Tanji et al., 
2002). 
Single siRNA knockdown of the AKAPs in H9c2 cells revealed that loss of the following 
AKAPs: AKAP6, AKAP7, AKAP10, AKAP11, AKAP12, and AKAP13 induce the 
generation of the CT isoform (Figure 14C-H). Considering the relative abundance of 
the different AKAPs within the cells, and whether they affected the CT formation lead 
to the following conclusions: AKAP12 was the most abundant by 82.3%, while AKAP7 
was the least present by 0.6% in the H9c2 cells (Figure 13C), which means that 





nucleoli by 63% in the absence of AKAP12 compared to untreated cells (Figure 13F), 
while in the absence of the AKAP7 it increased by 40% (Figure 13D). Taking into 
account the relative abundance with the measured pCt intensity would theoretically 
mean that loss of AKAP7 is ~125 times more efficient in increasing pCt intensity than 
loss of AKAP12. Following this thought, it would mean that loss of AKAP7 increases 
the pCt intensity 3.7 times more efficiently than loss of AKAP6, 1.52 times more 
efficiently than loss of AKAP10, 2.6 times more efficiently than loss of AKAP11, and 
4.2 times more efficiently than loss of AKAP13. Although such calculation is irrelevant, 
because of the limitations of the technique, it supports the notion that the relative gene 
expression levels do not always reflect extent of the gene function. Furthermore, 
AKAPs form complexes with multiple enzymes resulting in variety of signaling events, 
which can lead to differences in the CT isoform generation. Nevertheless, an 
implication of these observations could be that the loss of AKAP12 globally increased 
the PKA accessibility, while loss of AKAP7 locally increased it. This explanation would 
be in line with the findings that AKAP7 forms multivalent complex with the LTCC (Wong 
& Scott, 2004), while AKAP12 is not (Diviani et al., 2016). In addition, neither loss of 
AKAP2 (Figure 14A) nor AKAP5 (Figure 14B) had effect on the CT isoform generation. 
Double knockdown of AKAP5 together with WNT11 revealed that AKAP5 is not 
involved in the CT isoform generation (Figure 15B). The fact that AKAP5 forms 
multivalent complex with the LTCC (Wong & Scott, 2004), and is not involved in the 
CT isoform formation, raised the question why loss of AKAP5 did not increase the CT 
formation, while the other AKAPs did. One explanation could be that since AKAP5 can 
bind simultaneously PKA, PKC, and PP2B (Klauck et al., 1996), the loss of AKAP5 
besides PKA also induces the availability of PKC and PP2B creating an equilibrium in 
the channel regulation. To address whether the absence of these AKAPs effect the 
local PKA activity, thereby the CT formation FRET or BRET assay would be an option 
to perform. Surprisingly, in the absence of AKAP2, the loss of WNT11 had only mild 
effect on the pCt intensity in the nucleoli (Figure 15A) suggesting that the increment in 
local PKA activity is inefficient without the AKAP2 to regulate the CT isoform 
generation. On the other hand, neither loss of AKAP2 or application of the L314E 
peptide could completely rescue the loss of WNT11 phenotype, which may indicate 
the direct binding of PKA to the channel.  
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The ability of AKAP2 to bind PKA-RII subunit was established many years ago (Dong 
et al., 1998), however later data indicated its dual specificity (Aye et al., 2009). This is 
in line with the protein spotting data, which suggested that AKAP2 forms complex with 
the PKA regulatory subunit Ia and IIa (Figure 17). AKAP2 was shown to have at least 
six isoforms, which are differentially expressed in various tissues (Dong et al., 1998), 
most of these isoforms are enriched in H9c2 cells (Figure 18A). However, FLAG-IP of 
the FLAG-CT-mVenus construct and detection with AKAP2 antibody only resulted in a 
~130 kDa band (Figure 19B), which suggests that the CT construct only binds to one 
of the AKAP2 isoforms. Reciprocal co-IP strengthened the evidence of the interaction 
between AKAP2 and the CT construct (Figure 19C), and the binding between 
endogenous proteins was also confirmed (Figure 20B).  
WNT11/Calcium signaling plays an important role in establishing the intracellular 
calcium concentration, thereby regulating a range of intracellular events. It is likely that 
in the absence of this signaling such compensatory mechanisms become active, which 
can restore the intracellular calcium concentration. The immunoprecipitation data 
indicate the existence of a novel LTCC multivalent complex composed by AKAP2, 
PKA, and LTCC. The loss of WNT11 leads to increased intracellular calcium 
concentration (Panáková et al., 2010), and to the AKAP2-dependent generation of the 
CT isoform suggesting that the loss of WNT11 induces the formation of this 
AKAP2/PKA/LTCC complex to regulate the intracellular calcium concentration. 
Furthermore, the observation that CT acts as a transcription factor, which can prevent 
its own promoter activity (Schroder et al., 2009) indicates a dynamic regulatory system 
between WNT11 and the LTCC. In addition, qPCR data might suggest the relevance 
of other regulatory feedback loops in this system, because downregulation of WNT11 
in H9c2 cells induced the expression of the AKAP2 (Figure 16A), while downregulation 
of AKAP2 decreased the expression of WNT11 (Figure 16B).  
In summary, these findings suggest the existence of a novel AKAP2/PKA/LTCC 
complex next to the known complexes, which consists either AKAP5 or AKAP7. In 
contrast with the other two complexes, which regulate the generation of the dCT 
isoform, AKAP2/PKA/LTCC complex can regulate the cleavage of the CT isoform 






4.3 Akap2 functions during heart development  
Heart formation occurs through an evolutionary conserved program, which involves a 
complex series of morphogenetic events. During zebrafish cardiac development cells 
derived from anterior lateral plate mesoderm converge and fuse to form linear heart 
tube along the ventral midline (~30 hpf) (Stainier et al., 1993). The linear heart tube 
then under the control of genes involved in establishing the left-right asymmetry bends 
to the right side creating left-right polarity (Capdevila et al., 2000). During the cardiac 
looping, which occurs between 30-48 hpf the heart loses its tubular form as the two-
chambers become morphologically distinguishable. In parallel, in the atrioventricular 
canal the action potential propagation becomes slow, which results in contraction delay 
between the atrium and the ventricle, and the peristaltic contraction is replaced by 
sequential contraction (Chi et al., 2008). As the chambers are ballooning, the 
conduction velocity within the ventricle is increasing specially in the outer curvature to 
enable the cardiomyocytes to contract synergistically (Chi et al., 2008). It has been 
shown that establishing the electrical gradient formation requires Wnt11 signaling 
(Panáková et al., 2010). Furthermore, the observation that the electrical gradient 
formation in wnt11-deficient heart can be rescued by inhibition of the LTCC indicates 
that wnt11 can regulate the electrical gradient formation via attenuation of the LTCC 
conductance (Panáková et al., 2010). 
Beside that the Wnt11 signaling regulating the myocardial electrical gradient formation, 
it has been shown to regulate cardiac looping as well (Choudhry & Trede, 2013). This 
is in line with the findings that the looping angle was enlarged in wnt11 morphant heart 
by ~13.6° compared to uninjected control embryos (Figure 29). Furthermore, 
measuring the action potential propagation in either wnt11 morphant or mutant 
embryos confirmed that the loss of wnt11 abolishes the electrical gradient formation in 
developing zebrafish heart (Panáková et al., 2010). Since, the ratio between the 
conduction velocities in the OC and IC in wnt11 mutant was at 1.65 and in wnt11 
morphant 1.47. Surprisingly, in wnt11 mutants the mRNA expression of the cacna1c 
gene, which encodes the α1C subunit of the LTCC was significantly reduced (Figure 
24) suggesting the Wnt11 role in regulation of the channel expression. Since for the 
qPCR analysis whole zebrafish embryo RNA extract was used, it is not clear whether 
Wnt11 regulates the channel expression in cardiomyocytes. Furthermore, in the 
absence of the Wnt11 the dCT expression was the most effected. The dCT function as 
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a transcription factor has been previously shown (Gomez-Ospina et al., 2013). It can 
be transcribed independently from the cacna1c gene and repress its own promoter 
activity (Gomez-Ospina et al., 2013). In the light of these facts the regulation of the 
dCT expression via Wnt11 pathway might ensure a regulatory feedback loop. LTCCs 
are enriched in transverse-tubules (T-tubules), which are invaginations of the 
plasmamembrane that form a complex network of ducts (Brette & Orchard, 2003). The 
local accumulation of the LTCCs is indespensible for calcium induced calcium release 
with nearby RyRs, hence for establishing E-C coupling. Although the adult zebrafish 
cardiac muscle lacks T-tubules (Iorga et al., 2011), in wild-type embryos the LTCCs 
form clusters at the cell-cell boundaries (Figure 26B). The formation of these custers 
along the cell membranes was desturbed in wnt11-deficient hearts (Figure S6). 
Altogether, these findings suggest a more dynamic and complex regulatory 
mechanism in zebrafish between Wnt11 signaling and LTCC than compared to H9c2 
cells.  
Furthermore, analysing the expression of the akap genes in zebrafish embryos 
revealed that they are differentally expressed compared to H9c2 cells. For instance, 
AKAP5 that regulates the LTCC conductance in mammalian cardiomyocytes (Diviani 
et al., 2016) has no zebrafish orthologues. The akap6, which establishes the 
intracellular calcium levels in mammalian CMs (Diviani et al., 2016) is not expressed 
in zebrafish CMs. In addition, measuring the relative ratio between the relative amounts 
of the akaps indicated that akap2 is one of the most abundant akap in the zebrafish 
CMs (Figure 13B). These observations indicate that in zebrafish cardiomyocytes akap2 
might have broader function than in mammalian CMs. Analyzing the loss of akap2 
phenotype revealed that akap2-deficient embryos display decreased body size, 
perturbed brain structures, and heart edema (Figure 22A). Furthermore, loss of akap2 
effected the heart looping in little bit less than half of the embryos. Most of these 
embryos had unlooped hearts, in which case the looping angle occurred around 62.4° 
(Figure 23), while some of them (less than 10%) developed inverted hearts (Figure 
22B). It has been previously proposed that in prostate cancer cells, AKAP2 induces 
cell invasion and proliferation downstream of the calcitonin mediated pathway via 
destabilizing the cell-cell junctions (Thakkar et al., 2016). Immunostaining experiments 
using akap2-deficinet embryonic zebrafish heart strengthened this observation. At 54 





an inner endothelial monolayer (endocardium). However, in akap2-deficient heart the 
structure of the myocardium and endocardium was perturbed. The extracellular matrix 
between the two layers is increased, meanwhile the endocardium became compact 
(Figure 25C’). Furthermore, in some parts of the ventricle the monolayer of the 
myocardium was replaced by double layer (Figure 25C’). Since the proper looping of 
the heart requires cell rearrangement (Männer, 2009), it is very likely that the unlooped 
heart phenotype can originate from the disturbance in the cell-cell junctions. The action 
potential propagation was also effected in akap2-deficient ventricle. The ratio of the 
conduction velocities in these embryos between the OC and IC was significantly 
reduced compared to the wild-type embryos (Figure 30B). This might be the 
consequence of that in akap2-deficient heart the localization of the α1C subunit was 
altered. In akap2-deficient ventricle the longitudinal clusters of the LTCCs were less 
defined and instead LTCCs were localized more equally along the cell-cell boundaries 
(Figure 27C), which might indicate that the cluster formation of the LTCC in the 
subcellular microdomains is impaired in the absence of Akap2. These results 
combined with the previous finding that AKAP2/PKA interaction was highly increased 
in human patients diagnosed with DCM (Aye et al., 2012) strongly suggest that AKAP2 
has a pivotal function in the regulation of the E-C coupling.  
The current study suggests that AKAP2 assembles with LTCC and PKA and regulates 
the formation of the CT isoform on Wnt11 signaling dependent manner. To 
demonstrate whether this multivalent complex is involved in the electrical gradient 
formation downstream of the Wnt11 pathway, double akap2; wnt11 morpholino 
injected embryos were utilized. Phenotype analysis of the double morphant embryos 
revealed that some but not all of the phenotypic characteristics of the wnt11 morphant 
were rescued by knockdown of akap2. For instance, in the double morphant the body 
length and brain structure resembled the wild-type phenotype. However, to ensure that 
loss of akap2 indeed enable the rescue of the forebrain abnormalities in wnt11 
morphant further studies are required. Furthermore, most of the double morphant 
embryos developed cardiac looping defect; less than half of the cases were 
accompanied with fused eyes (Figure 28B). Double knockdown of akap2 together with 
wnt11 resulted in enhanced looping angle as single knockdown of the akap2 did, 
however this unlooped phenotype was less strong as in akap2-decficient heart (Figure 
29B). Considering that loss of Wnt11 signaling leads to disturbed Wnt11/PCP and 
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Wnt11/Calcium signaling this data may imply that loss of akap2 abolished the effect of 
the loss of Wnt11/Calcium pathway, but could not rescue the loss of Wnt11/PCP effect.  
Interestingly, the conduction velocities in double morphant resembled the wild-type 
conduction phenotype as the ratio between the conduction velocity of the OC and IC 
was 3.22 ± 0.60 (Figure 32) indicating that akap2 rescued the loss of wnt11 phenotype. 
It has been shown that knockdown of the core components of the Wnt11/PCP pathway 
has no effect on the electrical gradient formation (Panáková et al., 2010). This 
observation, and the findings of these experiments that loss of akap2 could not rescue 
the loss of wnt11 phenotype regarding the heart looping, but restored the action 
potential propagation in wnt11-deficient heart suggesting that Akap2 acts downstream 
of Wnt11/Calcium pathway. 
Taken together these data suggest, that in developing zebrafish embryos the Akap2 
regulates the heart development. Embryos which lack Akap2 develop unlooped heart 
and had disturbed action potential propagation, which implies that failure in Akap2 
anchored PKA signaling might be the cause of a number of cardiomyopathies. 
Furthermore, the findings that the absence of the Wnt11 signaling abolished the 
electrical gradient formation, however knockdown of Akap2 rescued the action 
potential propagation lead me to the conclusion that Akap2 might be the downstream 















5 Conclusions and Outlook 
 
The current study provides evidence that Wnt11 signaling pathway modulates the 
LTCC conductance, hence regulates the electrical gradient formation in developing 
zebrafish heart. In H9c2 cell, Wnt11 signaling prevented the CT of the α1C subunit of 
the LTCC from proteolytic processing. These findings are based on the observations 
that the loss of WNT11 unaltered the expression of the CACNA1C gene, which 
encodes the α1C subunit. However, loss of WNT11 and FZD7 induced the formation 
of the CT isoform. Furthermore, stimulation of β-AR/Gs pathway resembled the loss of 
WNT11/FZD7 phenotype, which indicates that either downregulation of the FZD7/Gi 
system or stimulation of β-AR/Gs pathway induces the cleavage of the CT isoform. 
Applying PKA inhibitor on WNT11 siRNA transfected cells revealed that the formation 
of the CT isoform is inefficient in the absence of the active PKA. Many studies 
suggested that compartmentalized cAMP activation is partially achieved via AKAPs. 
These scaffolding proteins enable the efficient local PKA signaling via directing the 
PKA to its phosphorylation targets. Applying a peptide, which disrupts the AKAP 
anchored PKA signaling in WNT11 siRNA transfected cells suggested that AKAP 
anchored PKA signaling is important in the formation of the CT isoform downstream of 
the Wnt11 pathway. 
Systematic analysis of the AKAPs using single knockdown of the AKAPs and double 
knockdown of the AKAPs together with WNT11 by siRNA transfection in H9c2 cells 
revealed that AKAP2 plays pivotal role in the generation of the CT isoform downstream 
of the Wnt11 signaling. Furthermore, co-IP experiments suggest the existence of a 
novel LTCC multivalent complex composed by LTCC, AKAP2, and PKA. These 
findings indicate that WNT11 pathway negatively regulates the formation of the 
LTCC/AKAP2/PKA complex, which induces the generation of the CT isoform. 
To investigate whether this complex is involved in the myocardial electrical gradient 
formation I performed single knockdown of akap2 and double knockdown of akap2 
together with wnt11 in developing zebrafish embryo using morpholino approach. 
akap2-deficient embryos developed heart edema and most of them had looping defect. 
Furthermore, loss of Akap2 effected the electrical gradient formation in the developing 
ventricle, which suggested that Akap2 is essential during cardiogenesis. In addition, 
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Conclusion and Outlook 
the akap2; wnt11 double morphant embryos had milder looping defect, however 
resembled the wild-type conduction phenotype. These observations that in wnt11-
deficient heart akap2 could not rescue the abnormal heart looping, but restored the 
action potential propagation, brought me to the conclusion that Akap2 acts 
downstream of the Wnt11/Calcium signaling.  
Taken together these results suggest, that Wnt11 signaling can modulate the channel 
conductance, hence the electrical gradient formation by antagonizing the β-AR/Gs 
signaling and preventing the CT isoform generation, which requires AKAP2 anchored 






Figure 33: Model of AKAP2/LTCC/PKA complex regulated by Wnt11/Calcium 
signaling. Wnt11/Calcium pathway regulates the CT isoform generation via 
AKAP2/LTCC/PKA complex. LTCC- L-type calcium channel, AKAP- A-kinase-anchoring 
protein, DVL-Dishevelled, FZD7- Frizzled 7, β-AR- β-Adrenergic Receptor, Eph- 
Epinephrine, GαI subunit- αI, Gβ subunit- β, Gγ subunit- γ, EC- Extracellular, IC-
Intracellular. 
 




The Wnt11 signaling and its relevance during development has been extensively 
demonstrated, however its function in cardiac biology as an alternative GPCR like 
system needs to be elucidated. Future studies should aim to define the downstream 
components of this pathway, and whether they regulate the formation of the AKAP2 
complex. Since only very limited information is available about this scaffolding protein 
it would be important to identify its interacting partners and build up-to-date protein 
interactome networks. Current study proposes that AKAP2 has pivotal role in 
regulating the LTCC and establishing the electrical gradient formation in developing 
zebrafish ventricle. Further investigation should explore, which domains are important 
in the AKAP2/LTCC interaction and define the cleavage site on the CT. Furthermore, 
it has been shown that AKAP2/PKA interaction was upregulated in patients diagnosed 
with DCM (Aye et al., 2012), which together with the findings of this study makes 
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Unconjugated, Clone AC-15 
Sigma-Aldrich  Cat# A5441; RRID:AB_476744 
Rabbit Anti-Nucleolin Antibody Abcam Cat# ab22758; RRID:AB_776878 
Anti-Calcium Channel Antibody, 
Voltage Gated α1C 
Millipore; 
(Dolmetsch et al., 2001) 
Cat# AB5156-
50UL 
Alexa Fluor™ 633 Phalloidin Thermo Fisher Scientific; (Rosado et al., 2014) Cat# A22284 
Mouse Anti-CACH2C Monoclonal 




Rabbit Anti-Human / Rat 
Connexin-43 Antibody, 
Unconjugated 




(Song et al., 2017) Cat# 9624S 
Mouse Anti-AKAP-KL Monoclonal 
Antibody, Unconjugated, Clone 
41 
BD Biosciences Cat# 611134; RRID:AB_398445 




Rabbit Anti-GFP Polyclonal 
Antibody, Unconjugated GeneTex 
Cat# GTX113617; 
RRID:AB_1950371 
Mouse Anti-ZN8 Hybridoma Bank RRID:AB_531904 









Anti-rabbit IgG, HRP-linked 
Antibody Cell Signaling 
Cat# 7074, 
RRID:AB_2099233 
Anti-mouse IgG, HRP-linked 
Antibody Cell Signaling 
Cat# 7076, 
RRID:AB_330924 
Goat Anti-Rabbit IgG (H+L) 
Antibody, Alexa Fluor®  488 
Conjugated 
Thermo Fisher Scientific Cat# A-11008, RRID:AB_143165 




Donkey Anti-Mouse IgG (H+L) 
Antibody, Alexa Fluor® 555 
Conjugated 
Thermo Fisher Scientific Cat# A-31570, RRID:AB_2536180 
Bacterial Strains  
Subcloning Efficiency™ DH5α™ 
Competent Cells Thermo Fisher Scientific Cat# 18265017 
One Shot™ TOP10 Chemically 
Competent E. coli Thermo Fisher Scientific Cat# C404006 
Chemicals and Peptides 














(Hundsrucker et al., 
2006) 
N/A 
DharmaFECT 1 Transfection 
Reagent Dharmacon Cat# T-2001-03 
Lipofectamine™ 2000 
Transfection Reagent Thermo Fisher Scientific Cat# 11668027 
cOmplete™, Mini, EDTA-free 
Protease Inhibitor Cocktail Sigma-Aldrich Cat# 04693159001 
PhosSTOP™ Sigma-Aldrich Cat# 04906845001 
Anti-FLAG® M2 Magnetic Beads Sigma-Aldrich Cat# M8823 
Dynabeads™ Protein A for 
Immunoprecipitation Thermo Fisher Scientific Cat# 10001D 
Penicillin-Streptomycin (10,000 
U/mL) Thermo Fisher Scientific Cat# 15140148 
MEM Non-Essential Amino Acids 
Solution (100X) Thermo Fisher Scientific Cat# 11140050 
TRIzol™ Reagent Thermo Fisher Scientific Cat# 15596026 
Cytochalasin D Sigma-Aldrich Cat# C8273; CAS:22144-77-0 
Tricane Sigma-Aldrich Cat# A5040 ; CAS: 886-86-2 
Anti-Calcium Channel Antibody, 
Voltage Gated α1C Antigen Millipore 
Cat# AB5156-
50UL 
Isoproterenol hydrochloride Sigma-Aldrich #1351005; CAS:51-30-9 
Critical Commercial Assays 
FluoVolt™ Membrane Potential 
Kit Thermo Fisher Scientific Cat# F10488 
In-Fusion® HD Cloning System Takara Bio USA Inc. Cat# 639648 
First Strand cDNA Synthesis Kit Thermo Fisher Scientific Cat# K1612 
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RNase-Free DNase Set Qiagen Cat# 79254 
RNeasy Mini Kit Qiagen Cat# 74104 
Phusion High-Fidelity DNA 
Polymerase (2 U/µL) Thermo Fisher Scientific Cat# F530S 
mMESSAGE mMACHINE™ T3 
Transcription Kit Thermo Fisher Scientific Cat# AM1348 
Poly(A) Tailing Kit Thermo Fisher Scientific Cat# AM1350 
Gateway™ BP Clonase™ II 
Enzyme mix Thermo Fisher Scientific Cat# 11789020 
Gateway™ LR Clonase™ II 
Enzyme mix Thermo Fisher Scientific Cat# 11791020 
GeneJET Gel Extraction Kit Thermo Fisher Scientific Cat# K0691 
Experimental Models: Cell Lines 
Rat H9c2 (2-1) ATCC CRL-1446 
Experimental Models: Organisms/Strains 
Zebrafish: Tg(myl7:EGFP)twu26:  
twu26Tg (Huang et al., 2003) 
ZFIN ID: ZDB-
ALT-070530-1 
Zebrafish: wnt11tx226 (Heisenberg et al., 2000) ZFIN ID: ZDB-ALT-980203-1302 
Zebrafish: AB/TL wild-type   
Oligonucleotides 
Primers for RT-PCR Figure S1A, 
see Table S1 This paper N/A 
ON-TARGETplus Rat siRNA, see 
Table S2 Dharmacon N/A 
TaqMan™Gene Expression 
Assay, see Table S3 Thermo Fisher Scientific N/A 
Primers for ISH, see Table S1  This paper N/A 
Primers for Danio akap2 mRNA, 
see Table S1 This paper N/A 
Primers for akap2 cDNA, see 
Table S1 This paper N/A 
Primers for CRISPR-Cas9 
experiment, see Table S1 This paper N/A 




This paper N/A 









pGEM®-T Easy Vector Systems Promega Cat# A1360  
pBluescript KS   
MGC Rat Akap2 cDNA Dharmacon 
Cat# MRN1768-
202780602; 
Clone ID: 7108964 
Plasmid: GeneArt® cDNA Rat 
Cacna1c aa(1350-2090) Thermo Fisher Scientific N/A 




Gateway™ pDONR™221 Vector Thermo Fisher Scientific Cat# 12536017 
pFRT_TO_DESTFLAGHA Addgene Cat# 26361 
Software and Algorithms 
ImageJ Fiji https://imagej.net/Fiji/Downloads 
Adobe Illustrator CS5.1  
Adobe Photoshop CS5.1  
Image Studio Lite  
GraphPad Prims 6 https://www.graphpad.com/scientific-software/prism/ 
MATLAB (MathWorks) https://www.mathworks.com/products.html?s_tid=gn_ps 
Leica Application Suite (LAS)  





QuantStudio™ 7  
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6.2.1 Zebrafish methods 
6.2.1.1 Ethics Statement 
All zebrafish husbandry and experiments were performed in accordance with 
guidelines approved by the Max-Delbrück Center for Molecular Medicine at the 
Helmholtz Association and the local authority for animal protection (Landesamt für 
Gesundheit und Soziales, Berlin, Germany) for the use of laboratory animals, and 
followed the “Principles of Laboratory Animal Care’ (NIH publication no. 86-23, revised 
1985) as well as the current version of German Law on the Protection of Animals 
6.2.1.2 Zebrafish husbandry  
Zebrafish were maintained under continuous water flow and filtration with automatic 
control for a 14:10 hours (h) light/dark cycle at 28.5°C. Fertilized eggs were collected 
and raised under standard laboratory conditions (at 28.5°C in E3 solution (5 mM NaCl, 
0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, pH 7.4)). The following zebrafish 
lines were used: AB/TL wild-type line, Tg(myl7:eGFP) twu34 transgenic line (Huang et 
al., 2003) and wnt11tx226 mutant line (Heisenberg et al., 2000). 
6.2.1.3 Bright field imaging 
54 hpf embryos were either anesthetized using 4 mg/ml Tricane (pH~7) or fixed in 
PEM solution (100 mM PIPES, 2 mM MgSO4, 1mM EGTA, pH 7) with 4% 
Formaldehyde and 0.1% Triton X-100 for 2 h, at RT  and mounted in 2% 
methylcellulose. For imaging Leica Fluorescence Stereo Microscope M165 equipped 
with Leica DFC450C camera and LAS-V4.7 software was used. Images were 
processed using ImageJ Fiji and Adobe Photoshop CS5.1. 
6.2.1.4 Microinjection 
The night before injection, male and female fish were placed in a 1l tank and 
separated. At morning, zebrafish embryos were obtained by removing the divider. 
The morpholino injection solution was prepared from RNase/DNase free water and 
1mM akap2 morpholino in a ratio 1:1 or 1mM wnt11 morpholino in a ratio 1:6. After 
incubation at 65°C for 10 min 1 nl morpholino solution was injected per embryo into 




the yolk of 1-4 cell stage embryos. 1 nl capped akap2 mRNA was injected into 1-cell 
stage embryos (concentration is indicated on the figures).  
6.2.1.5 Heart looping measurement 
Heart angle was defined as the angle enclosed by the midsagittal line and the 
atrioventricular canal. For the images 54 hpf fixed embryos were used, embed in 2% 
methylcellulose. Images were analyzed using ImageJ Fiji. 
6.2.1.6 Optical mapping of action potential propagation 
Optical mapping and signal processing was performed as described previously 
(Panáková et al., 2010). Hearts were isolated from 54 hpf zebrafish embryos  in 
normal Tyrode’s solution (NST contains 136 mM NaCl, 5,4 mM KCl, 1mM 
MgCl2x6H2O, 5mM D-(+)-Glucose, 10mM HEPES, 0.3 mM Na2HPO4x2 H2O, 1. mM 
CaCl2x2 H2O, pH 7.4) supplemented with 20 mg/ml BSA. To record membrane 
potential changes, hearts were stained for 12 minus with FluoVolt probe (Thermo 
Fisher Scientific), and washed with NST-BSA. Individual hearts were transferred into 
perfusion bath (Warner Instruments), which contained NST supplemented with 100 
µM Cytochalasin D to inhibit contraction. For the imaging high-speed CCD camera 
(RedShirt Imaging) was used equipped with LED lamp and NeuroPlex software. 
Images were analyzed with MatLab (MathWork) using customized software 
(Panáková et al., 2010). 
6.2.1.7 Zebrafish AKAP2 mRNA construction 
Zebrafish akap2 (ENSDARG00000069608) mRNA was constructed by PCR 
amplification of cDNA using Danio rerio akap2 infusion primers (see Table S1), which 
were designed with http://bioinfo.clontech.com/infusion/convertPcrPrimersInit.do. The 
cDNA fragment was cloned into pBluescript KS (-) vector with HindIII at the 5’-end and  
BamHI restriction enzyme site at the 3’-end using the In-Fusion® HD Cloning System. 
In vitro transcription was performed using mMessage mMachine T3 Transcription Kit 
and BamHI-linearized DNA template at 37°C. To increase translation initiation 
efficiency and transcript stability I performed polyadenylation of the mRNA using 
Poly(A) Tailing Kit.  
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6.2.1.8 Single-cell dissociation and FACS 
54 hpf myl7.EGFP transgenic embryos Tg(myl7:EGFP) were dechorionated using 
Pronase and incubated in 0.25% Trypsin at 28.5 °C. Single-cell dissociation was 
monitored every 20 minutes and was generally achieved within 2 hours of incubation. 
Efficient dissociation was helped by gentle pipetting. Cell suspension was filtered 
through 70 µM strainer and cells were exhaustively washed three times in cold PBS 
supplemented with Fetal Calf Serum in reducing concentration and eventually 
resuspended in 1 ml of cold PBS. Single cells were filtered in a glass tube with a cell 
strainer cap and placed on ice until counting. Samples were analyzed using a BD 
FACS Aria1 flow cytometer, operating with BD LSRFortessa analyzer with BD 
FACSDiva software. GFP expressing cells were identified using a 488nm laser and a 
530/30 BP filter. 
6.2.1.9 qPCR 
The total RNA was isolated from wild-type or wnt11tx226 mutant zebrafish embryos at 
54 hpf using the TRIzol reagent according to the manufacturer’s instruction. The RNA 
was digested with DNase set (Qiagen), cleaned with RNeasy Mini Kit (Qiagen) and 
reverse transcribed using First Strand cDNA Synthesis Kit. 100 ng of cDNA was used 
for real-time PCR analysis. The total RNA was isolated from EGFP positive cells of 
myl7.EGFP transgenic embryos Tg(myl7:EGFP) at 54 hpf, using the TRIzol reagent 
according to the manufacturer’s instruction. The RNA was reverse transcribed using 
First Strand cDNA Synthesis Kit. 10 ng of cDNA was used for real-time PCR analysis. 
The relative mRNA levels were quantified using gene-specific TaqMan assays (see 
Table S3) ViiA 7 Real-Time PCR System and Quant Studio 7. Results were analyzed 
using the comparative threshold cycle (2^-ΔΔCt) method (Livak & Schmittgen, 2001), 
normalized to housekeeping gene. The results are expressed as fold-increase of log2 
(2^-ΔΔCt) over mock. Statistical significance was assessed using ΔCt. 
6.2.1.10 Confocal microscopy 
Hearts were isolated from 54 hpf zebrafish embryos in normal Tyrode’s solution (pH 
7.4) supplemented with 20 mg/ml BSA and fixed in Glyo-Fixx for 12 minutes. 
Following primary antibodies were used: anti-II-III-loop (Millipore) 1:50; ZN8 
(Hybridoma Bank) 1:50. For the specificity validation of the II-III loop it was pre-




incubated with its peptide in a ratio 1:1 for 2h at RT. Confocal images were obtained 
on Leica TCS SP5 using LAS-FX software.  
 
6.2.2 Cell culture methods 
6.2.2.1 Cell culture and transfection 
H9c2(2-1) (rat [Rattus norvegicus] heart myoblast) cells were obtained from 
ATCC® (CRL-1446™), cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% of Fetal Bovine Serum (FBS), 1% of Penicillin-Streptomycin 
and 1% of Non-essential amino acids, and incubated at 37°C with 5% CO2.  
H9c2 cells were transfected for 24 h with a concentration of 50nM siRNA (see Table 
S2) using DharmaFECT 1 (Dharmacon) according to manufacturer’s instructions. 
H9c2 cells were transfected for 24 h  with a concentration of 200 ng/ml DNA using 
Lipofectamine™ 2000 (Thermo Fisher Scientific) according to manufacturer’s 
instructions. 
6.2.2.2 Rat AKAP2 Plasmid construction 
cDNA encoding rat AKAP2 was obtained (Dharmacon). FLAG/HA-tagged AKAP2 was 
cloned using Gateway technology (Invitrogen) by PCR amplification of the AKAP2 
cDNA using attB-flanked BP primers (see Table S1). attB-flanked PCR product was 
cloned first into a pDONR™221 vector using BP Clonase™ II Enzyme mix to generate 
entry clone, and subsequently transferring into a destination vector 
pFRT_TO_DESTFLAGHA to create expression clone using LR Clonase™ II Enzyme 
mix. 
6.2.2.3 Immunoprecipitation 
H9c2 cell were solubilized in mild lysis buffer (2mM EDTA, 2mM EGTA, Triton X-100 
in PBS) containing PhosSTOP and EDTA-free Protease Inhibitor Cocktail. Lysates 
were passed through a syringe of 0.4mm diameter, centrifuged at 5000xg at 4°C for 5 
minutes and quantified by Bradford’s protein estimation method (Anal. Biochem. 72, 
248-254 (1976)). Lysates were incubated over night at 4°C either with Anti-FLAG M2 
Magnetic Beads or with Dynabeads Protein A, which was beforehand incubated with 
AKAP2 or GFP antibody. Beads were washed four times with mild lysis buffer using 
magnetic separator. Immunoprecipitated proteins were eluted with 0.1M glycine (pH 
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2.5), neutralized with 1M Tris (pH 10.6) and denatured in 1x Laemmli sample buffer for 
7 min at 95°C. Eluted proteins were resolved on 10 % SDS-PAGE gels (home-made) 
and western blotted using standard procedure. The following primary antibodies were 
used: anti-AKAP2 (Bioscience) 1:500, anti-FLAG (Sigma) 1:1000 and anti-pCt 
(custom-made) 1:1000, anti-GFP (GeneTex) 1:4000. Chemiluminescent detection was 
performed, blots were visualized using Odyssey Fc Imaging System, LI-COR 
(Biosciences) and Image Studio Lite software. 
6.2.2.4 Peptide spots 
Peptides were spot-synthesized as 25 mers (see Table S4)  on a Whatman 50 
cellulose membrane using the AutoSpot-Robot ASS 222 (Intavis Bioanalytical 
Instruments) as described previously (Hundsrucker et al., 2010). Membranes were 
incubated with FLAG-IPed protein lysates and were detected using anti-FLAG (Sigma) 
1:1000, as for western blotting. Chemiluminescent detection was performed, blots 
were visualized using Odyssey Fc Imaging System, LI-COR (Biosciences) and Image 
Studio Lite software. 
6.2.2.5 Immunoblotting 
H9c2 cell lysates were prepared using RIPA buffer (20 mM Tris-HCl, 150 mM NaCl, 
0.1% Triton X-100, 0.1% SDS, 0.5% Sodium-deoxycholate, PhosSTOP, EDTA-free 
Protease Inhibitor Cocktail). Lysates were sonicated and centrifuged at 5000xg at 4°C 
for 5 minutes. Protein concentrations were quantified by Lowry’s estimation method. 
After addition of Laemmli buffer (50 mM Tris-HCl, 0.1% SDS, 9% Glycerol, 1% β-
mercaptoethanol, 0.02% Bromphenolblue, 25 mM DTT) lysate was cooked for 10 
minutes and centrifuged again 5000xg and 4°C for 5 minutes. Total protein was 
separated on 4-15% SDS-polyacrylamide gel (Bio Rad), and transferred to a 
Nitrocellulose Blotting membrane (GE Healthcare). The following concentration of the 
primary antibodies were used: anti-AKAP2 (Bioscience) 1:1000, anti-β-actin (Sigma) 
1:3000 and anti-pCt (custom-made) 1:1000. Chemiluminescent detection was 
performed using Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific). All 
western blots were quantified with ImageJ Fiji. 
6.2.2.6 qPCR 
The total RNA was isolated from cultured H9c2 cells using the TRIzol reagent 
according to the manufacturer’s instruction. The RNA was digested with DNase set 




(Qiagen), cleaned with RNeasy Mini Kit (Qiagen) and reverse transcribed using First 
Strand cDNA Synthesis Kit. 50 ng of cDNA was used for real-time PCR analysis. The 
relative mRNA levels were quantified using gene-specific TaqMan assays (see Table 
S3) ViiA 7 Real-Time PCR System and Quant Studio 7. Results were analyzed using 
the comparative threshold cycle (2^-ΔΔCt) method (Livak & Schmittgen, 2001), 
normalized to housekeeping gene. The results are expressed as fold-increase of log2 
(2^-ΔΔCt) over mock. Statistical significance was assessed using ΔCt. 
6.2.2.7 RT-PCR 
The total RNA was isolated from cultured H9c2 cells and from 54 hpf zebrafish 
embryos using the TRIzol reagent according to the manufacturer’s instruction. The 
total RNA was reverse transcribed using First Strand cDNA Synthesis Kit and amplified 
using Phusion polymerase with primers for the interested genes (see Table S1). The 
PCR products were visualized using 3% agarose gel and Redsafe staining. 
6.2.2.8 Drug treatment 
H9c2 cells were plated for 48 hours prior to the experiment and incubated with the 
following drugs: 10 µM FSK, 10 µM PKI, 100 µM L314E for 1 hour or with 4 µM ISO 
for 3 minutes and with corresponding concentration of DMSO before harvesting or 
fixation. 
6.2.2.9 Confocal microscopy 
H9c2 cells were plated on poly-D-lysine coated coverslips 48 hours prior to the 
experiments and fixed after 24 hours transfection or after drug treatment in PBS 
supplemented with 4% PFA and 4% Sucrose for 20 minutes. Following primary 
antibodies were used: anti-II-III-loop (Millipore) 1:100; anti-F-actin (Thermo Fisher 
Scientific) 1:4; anti-pCt (Abnova) 1:500; anti-nucleolin (Abcam) 1:500. Confocal 
images were obtained on Leica TCS SP8 using LAS-FX software. For the localization 
studies, intensity was measured using ImageJ Fiji and maximal Z-projection. 
 
6.2.3 Data and statistical analysis 
All the graphs were generated and analyzed using GraphPad Prism 6. Data represent 
the mean ± SD of independent experiments indicated in figure legends. Statistical 
significance was assessed with Welch’s test, Wilcoxon test or Mann-Whitney test. P 
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value of less than 0.05 was considered to be statistically significant. The levels of 
statistical significance were indicated as follows:  *P < 0.05; **P < 0.01; ***P < 0.001; 


























7.1 Supplementary figures 
 





















Supplementary Figure 1: Efficient knock down of the indicated gene using siRNA. (A) 
Relative mRNA expression of WNT11, FZD7 and CACNA1C genes were measured in 
Untransfected (Unt), Scramble, WNT11 ((-)WNT11), FZD7 ((-)FZD7) or CACNA1C ((-
)CACNA1C) siRNA transfected H9c2 cell via quantitative RT-PCR and normalized to the 
relative mRNA expression of GAPDH in Scramble siRNA transfected cells. Data represent 
the fold change log2 (2^-∆∆Ct) of the interested genes. (Mean ± SD of N = 3 experiments; 
ns P(WNT11 in Unt)=0,0625; *P(WNT11 in (-)WNT11)=0.0156; ns P(FZD7 in Unt)=0.6406; 
**P(FZD7 in (-)FZD7)=0.0039; ns P(CACNA1C exon 18 in Unt)=0.0547;             
**P(CACNA1C exon 18 in (-)CACNA1C)=0.0039; ns P (CACNA1C exon 39 in Unt)=0.0547; 
**P(CACNA1C exon 39 in (-)CACNA1C)=0.0039; ns P(CACNA1C exon 45 in Unt)=0.0977; 
**P(CACNA1C exon 45 in (-)CACNA1C)=0.0039; Wilcoxon test). 
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Supplementary Figure 2: 
Verification of the anti-II-
III-loop and anti-pCt 
antibodies. Maximum 
intensity projection of 
confocal images of 
untreated, Scramble and 
CACNA1C siRNA 
transfected H9c2 cells. 
Following primary 
antibodies were used for 
the immunostaining: (A) 
anti-II-III-loop (Millipore) in 
dilution of 1:100 (gray/ 
green), anti-F-actin 1:4 
(gray) or (B) anti-pCt 
(Abnova) 1:500 (gray/ 
magenta), anti-F-actin 1:4 
(gray) and anti-Nuc 1:500 
(green). DAPI (blue) 
staines nucleus. (N ≥ 3 
experiments; n ≥ 79). The 
















Supplementary Figure 4 
 
 
Supplementary Figure 3: Efficient downregulation of the preselected AKAPs in H9c2 
cell. (A-H) Relative mRNA expression of the interested AKAP gene was measured in 
untreated, Scramble and corresponding AKAP siRNA transfected H9c2 cell via quantitative 
RT-PCR and normalized to the relative mRNA expression of GAPDH in Scramble siRNA 
transfected cells. Data represent the fold change log2 (2^-∆∆Ct) of the indicated gene.     
(Mean ± SD; N = 3 experiments; (A) ns P(Unt)=0.4258; **P((-)AKAP2)=0.0039;                                       
(B) ns P(Unt)=0.0742; **P((-)AKAP5)=0.0039; (C) ns P(Unt)=0,3594;                                       
**P((-)AKAP6)=0,0039; (D) ns P(Unt)=0,3008; **P((-)AKAP7)=0.0039.                                         
(E) nsP(Unt)=0.19510; **P((-)AKAP6)=0.0039; (F) ns P(Unt)=0.2188;                                      
**P((-)AKAP11)=0.0039; (G) ns P(Unt)=0.9453; **P((-)AKAP12)=0.0078;                                   
(H) ns P (Unt)=0.4258; **P((-)AKAP13)=0.0039; Wilcoxon test). 
 
Supplementary Figure 4: Phenotype analysis of akap2 mRNA injected embryos. 
Phenotype analysis of (A) 50 pg/µl, (B) 75 pg/µl or (C) 100 pg/µl akap2 mRNA injected 
embryos considering the heart phenotype. (N ≥ 3 experiments; n ≥ 300). 
          Supplements 
























Supplementary Figure 5: Verification of the anti-II-III-loop. Maximum intensity projection 
of 7µm confocal section of WT zebrafish hearts at 54hpf. (A-B) DAPI (gray/blue) staines 
nucleus. Following primary antibodies were used for the immunostaining: (A’) anti-II-III-loop 
antibody (Millipore) in dilution of 1:50 (gray/green), (B’) anti-II-III-loop antibody (Millipore) 
was pre-incubated with its peptide (gray/green), (A’’ and B’’) anti-ZN8 (Hybridoma Bank) in 






















Supplementary Figure 6: Localization and abundance of the α1C subunit. (A-I) 
Maximum intensity projection of 7µm confocal section of WT (A-C), wnt11ATGMO (D-F) and 
akap2e2i2MO (G-I) zebrafish hearts at 54hpf. Following primary antibodies were used for the 
immunostaining: anti-II-III-loop antibody (Millipore) in dilution of 1:50 (gray). (N=3 
experiments). The scale bar represents 10 µm. 
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7.2 Supplementary Tables  
 
Supplementary Table 1 
Primer name Used for Seq (5'->3') 
H9c2 Cacna1c Fw  RT-PCR Figure 5A ACG GCA CC TCT TAC CTT TT 
H9c2 Cacna1c Rv RT-PCR Figure 5A CCG ACA GCA GTG AAT GAA GA 
H9c2 Myogenin Fw RT-PCR Figure 5A TCG AGG CTC TGA AGA GAA GC 
H9c2 Myogenin Rv RT-PCR Figure 5A CAC GAT GGA CGT AAG GGA GT 
H9c2 Troponin T t2 Fw RT-PCR Figure 5A CAG AGA GGA GGA AGG TGC TG 
H9c2 Troponin T t2 Rv RT-PCR Figure 5A CCT GGC AAG ACC TAG AGC TG 
H9c2 Wnt11 Fw RT-PCR Figure 5A TCT GCG AGG CTC TTC TCT TC 
H9c2 Wnt11 Rv RT-PCR Figure 5A ACC TCT CTC CAG GTC AAG CA 
H9c2 Fzd7 Fw RT-PCR Figure 5A CAT GTT CCT CGG CTT CAT TT 
H9c2 Fzd7 Rv RT-PCR Figure 5A CTG CGT TCA TGC TGA TGA CT 
H9c2 Dvl2 Fw RT-PCR Figure 5A CCT TGG CCT GGT AAG TTT CA 
H9c2 Dvl2 Rv RT-PCR Figure 5A AAC AAC TGG AGG TGG TGG TC 
H9c2 β-catenin Fw RT-PCR Figure 5A GCC AGT GGA TTC CGT ACT GT 
H9c2 β-catenin Rv RT-PCR Figure 5A TCA GCA CTC TGC TTG TGG TC 
H9c2 GAPDH Fw RT-PCR Figure 5A GGT GAT GCT GGT GCT GAG TA 
H9c2 GAPDH Rv RT-PCR Figure 5A ACT GTG GTC ATG AGC CCT TC 
H9c2 Connexin 43 Fw RT-PCR Figure 5A GCT CCA CTC TCG CCT ATG TC 
H9c2 Connexin 43 Rv RT-PCR Figure 5A GAG TTC ATG TCC AGC AGC AA 
H9c2 Dvl1 Fw RT-PCR Figure 5A CTC TCT TGG GCT CTG TCA CC 
H9c2 Dvl1 Rv RT-PCR Figure 5A AGG CCT CTC TCC TGT CTT CC 
H9c2 Dvl3 Fw RT-PCR Figure 5A GCC TCA CGC CTA ATG AGA AG 
H9c2 Dvl3 Rv RT-PCR Figure 5A TCT CCC GAA GCA CTC TGA CT 
H9c2 akap2 attB1 FLAG-tagged AKAP2 GGGGACAAGTTTGTACAAAAAAGCAGGCTGGATGGAAATTGGGGTGTCCGTG 
H9c2 akap2 attB2 FLAG-tagged AKAP2 GGGGACCACTTTGTACAAGAAAGCTGGGTGTTATTCATTGTCCTCCTCCTC 
Danio rerio akap2 infusion 
Fw akap2 mRNA synthesis 
CGGTATCGATAAGCTTCGGGACACTCAG
GACTTCTAGC 
Danio rerio akap2 infusion 
Rv akap2 mRNA synthesis 
TAGAACTAGTGGATCCTTACTCTTCTTCT
TCCTCTTCC 
Danio rerio akap2 cDNA Fw akap2 MO verification CGG GAC ACT CAG GAC TTC TAG C 
Danio rerio akap2 cDNA Rv  akap2 MO verification ACT GTT GTC CTC GGC TTT CTC CC 
 
Supplementary Table 2 
siRNA name Source Identifier 
ON-TARGETplus Rat Non-targeting Control siRNA Dharmacon Cat# D-001810-01-20 
ON-TARGETplus Rat Wnt11 (140584) siRNA - SMARTpool Dharmacon Cat# L-101650-02-0010 
ON-TARGETplus Rat Cacna1c (24239) siRNA - SMARTpool Dharmacon Cat# L-080130-02-0010 
ON-TARGETplus Rat Cdk15 (301440) siRNA - SMARTpool Dharmacon Cat# L-084243-02-0005 





ON-TARGETplus Rat Akap5 (171026) siRNA - SMARTpool Dharmacon Cat# L-092699-02-0005 
ON-TARGETplus Rat Akap6 (64553) siRNA - SMARTpool Dharmacon Cat# L-091596-02-0005 
ON-TARGETplus Rat Akap7 (361458) siRNA - SMARTpool Dharmacon Cat# L-102358-02-0005 
ON-TARGETplus Rat Akap10 (360540) siRNA - SMARTpool Dharmacon Cat# L-083671-02-0005 
ON-TARGETplus Rat Akap11 (498549) siRNA - SMARTpool Dharmacon Cat# L-104261-02-0005 
ON-TARGETplus Rat Akap12 (83425) siRNA - SMARTpool Dharmacon Cat# L-088741-02-0005 
ON-TARGETplus Rat Akap13 (293024) siRNA - SMARTpool Dharmacon Cat# L-083007-02-0005 
 
Supplementary Table 3 
TaqMan probe name Source Identifier 
TaqMan™Gene Expression Assay 
(FAM), Rat Gapdh 
Thermo Fisher 
Scientific Cat#4331182; ID:Rn01775763_g1 
TaqMan™Gene Expression Assay 
(FAM), Rat Wnt11 
Thermo Fisher 
Scientific Cat#4331182; ID:Rn01510238_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Fzd7 
Thermo Fisher 
Scientific Cat#4331182; ID:Rn01441541_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Cacna1c exon 17/18 
Thermo Fisher 
Scientific Cat#4351372; ID:Rn01492559_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Cacna1c exon 38/39 
Thermo Fisher 
Scientific Cat#4351372; ID:Rn00709314_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Cacna1c exon 44/45 
Thermo Fisher 
Scientific Cat#4351372; ID:Rn01492578_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Akap2 
Thermo Fisher 
Scientific Cat#4331182; ID:Rn01422768_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Akap5 
Thermo Fisher 
Scientific Cat#4331182; ID:Rn01786021_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Akap6 
Thermo Fisher 
Scientific Cat#4331182; ID:Rn00575148_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Akap7 
Thermo Fisher 
Scientific Cat#4331182; ID:Rn01756034_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Akap10 
Thermo Fisher 
Scientific Cat#4351372; ID:Rn01496138_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Akap11 
Thermo Fisher 
Scientific Cat#4351372; ID:Rn01468361_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Akap12 
Thermo Fisher 
Scientific Cat#4331182; ID:Rn01643001_m1 
TaqMan™Gene Expression Assay 
(FAM), Rat Akap13 
Thermo Fisher 
Scientific Cat#4351372; ID:Rn01478249_m1 
TaqMan™Gene Expression Assay 
(FAM),  Zebrafish cacna1c exon 18 
Thermo Fisher 
Scientific Cat#4351372; ID: Dr03093529_m1 
TaqMan™Gene Expression Assay 
(FAM),  Zebrafish cacna1c exon 40 
Thermo Fisher 
Scientific Cat#4351372; ID: Dr03093552_g1 
TaqMan™Gene Expression Assay 
(FAM),  Zebrafish cacna1c exon 45 
Thermo Fisher 
Scientific Cat#4351372; ID: Dr03093556_g1 
TaqMan™ Gene Expression Assay, 
VIC primer-limited, Zebrafish 
eef1a1l1 
Thermo Fisher 
Scientific Cat#4448484; ID:Dr03432748_m1 
Custom TaqMan™ Gene 






Custom TaqMan™ Gene 
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Custom TaqMan™ Gene 
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Supplementary Table 4 
Peptide spots  Position Amino acid sequence 
PKA-RI 
A5 MESGS TAASE EARSL RECEL YVQKH 
A4 TAASE EARSL RECEL YVQKH NIQAL 
A3 EARSL RECEL YVQKH NIQAL LKDSI 
A2 RECEL YVQKH NIQAL LKDSI VQLCT 
A1 YVQKH NIQAL LKDSI VQLCT ARPE 
PKA-RIIa 
B10 MSHIQ IPPGL TELLQ GYTVE VLRQQ  
B9 IPPGL TELLQ GYTVE VLRQQ PPDLV  
B8 TELLQ GYTVE VLRQQ PPDLV EFAVE  
B7 GYTVE VLRQQ PPDLV EFAVE YFTRL  
B6 VLRQQ PPDLV EFAVE YFTRL REAR 
PKA-RIb 
C10 MASPP ACPSE EDESL KGCEL YVQLH 
C9 ACPSE EDESL KGCEL YVQLH GIQQV  
C8 EDESL KGCEL YVQLH GIQQV LKDCI  
C7 KGCEL YVQLH GIQQV LKDCI VHLCI  
C6 YVQLH GIQQV LKDCI VHLCI SKPER 
PKA-RIIb 
C5 MSIEI PAGLT ELLQG FTVEV LRHQP 
C4 PAGLT ELLQG FTVEV LRHQP ADLLE  
C3 ELLQG FTVEV LRHQP ADLLE FALQH  
C2 FTVEV LRHQP ADLLE FALQH FTRLQ  
C1 LRHQP ADLLE FALQH FTRLQ QENEA 
Control 
A9 AAAAA AAAAA AAAAA AAAAA AAAAA 
A8 AAAAA AAAAA AAAAA AAAAA AAAAA 
A7 AAAAA AAAAA AAAAA AAAAA AAAAA 
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APC Adenomatosis Polyposis Coli  
AC Adenylyl Cyclase  
AKAP A-Kinase Anchoring Protein 
ABD A-Kinase Anchoring Protein Binding Domain 
aa amino acid(s) 
AQP0 Aquaporin-0  
AF Atrial Fibrillation 
β-AR β-Adrenergic Pathway 
bp base pair(s) 
β-Cat  β-Catenin  
BSA Bovine Serum Albumin 
CCBs Calcium Channel Blockers  
CaMKII Calcium/Calmodulin dependent serine/threonine Kinase II  
CDI Calcium-dependent inhibition 
CaM Calmodulin 
CMs Cardiomyocytes 
CK1α Casein Kinase 1α  
JNK c-Jun N-terminal Kinase  
cDNA complementary Deoxyribonucleic Acid 
Cx43 Connexin 43  
CT C-terminal tail of the α1C subunit of the L-Type Calcium 
Channel 
cAMP cyclic Adenosine Monophosphate 
cGMP cyclic Guanosine Monophosphate 
DNase Deoxyribonuclease  
DAG Diacylglycerol 
DCM Dilated Cardiomyopathy  
DMSO Dimethyl Sulfoxide 
DVL Dishevelled 
Daam1 Dishevelled associated activator of morphogenesis 1  
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dCT distal C-terminal tail of the α1C subunit of the L-Type Calcium 
Channel 
DMEM Dulbecco’s Modified Eagle Medium  
F-HVM Failing Human Ventricular Myocyte(s)  
FBS Fetal Bovine Serum  
FACS Fluorescence-Activated Cell Sorting  
FSK Forskolin 
FZD Frizzled 
GSK3β Glycogen Synthase Kinase 3β  
GPCR G Protein-Coupled Receptor  
HDAC Histone Deacetylase  
h hour(s) 
hpf hour(s) post fertilization 
IP Immunoprecipitation 
IC Inner Curvature  





LZ Leucine-Zipper  
l liter 
LRP5/6 Low-density Lipoprotein Receptor related Protein 5/6  
LTCC L-Type Calcium Channel  








NCX Na+/Ca2+ Exchanger  
ng nanogram 
nl nanoliter 





NST Normal Tyrode’s Solution  
NFAT Nuclear Factor of Activated T cells  
OC Outer Curvature  
PFA Paraformaldehyde 
PBS Phosphate Buffered Saline 
PIP2 Phosphatidylinositol-4,5-bisphosphate  
PDE Phosphodiesterase 
PLN Phospholamban 
PLC Phospholipase C 
PCP Planar Cell Polarity  
PCR Polymerase Chain Reaction 
PKA Protein Kinase A  
PKC Protein Kinase C  
PKD Protein Kinase D  
PKI Protein Kinase Inhibitor  
PP1 Protein Phosphatase 1  
PP2A Protein Phosphatase 2A  
PP2B Protein Phosphatase 2B 
pCT proximal C-terminal tail of the α1C subunit of the L-Type 
Calcium Channel 
ROCK Rho-associated Kinase  
GEF Rho-Guanine nucleotide Exchange Factor  
RNase Ribonuclease  
RNA Ribonucleic acid 
RT Room Temperature 
RyR Ryanodine Receptor   
SR Sarcoplasmic Reticulum  
SERCA Sarcoplasmic Reticulum Ca2+-ATPase  
7TM Seven Transmembrane  
siRNA small interfering Ribonucleic Acid 
SD Standard Deviation  
TS Timothy syndrome 
TF Transcription Factor  
TPM Troponin-T 
WB Western Blot 
WT Wild-Type 
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